BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
476029	COc1ccc(CN2CCn3c(ccc(Nc4ccncn4)c3=O)C2=O)cc1	InChI=1S/C20H19N5O3/c1-28-15-4-2-14(3-5-15)12-24-10-11-25-17(20(24)27)7-6-16(19(25)26)23-18-8-9-21-13-22-18/h2-9,13H,10-12H2,1H3,(H,21,22,23)	CAHBUMFZCCBLQR-UHFFFAOYSA-N	162342	US9669031, 1 7-(pyrimidin-4-ylamino)-3,4-dihydro-1H-pyrido[1,2-a]pyrazine-1,6-(2H)-dione (Cpd. No. 1)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=162342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=162342&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598941	373986804							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476030	CC1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H13N5O2/c1-13(2)17-11(19)9-4-3-8(12(20)18(9)13)16-10-5-6-14-7-15-10/h3-7H,1-2H3,(H,17,19)(H,14,15,16)	YUDKTFUCCPOVGR-UHFFFAOYSA-N	164243	US9669031, 2 3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 2)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164243&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	FZJ	6CKI	118598721	373986840							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476031	CC1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H13N5O2/c1-13(2)17-11(19)9-4-3-8(12(20)18(9)13)16-10-5-6-14-7-15-10/h3-7H,1-2H3,(H,17,19)(H,14,15,16)	YUDKTFUCCPOVGR-UHFFFAOYSA-N	164243	US9669031, 2 3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 2)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164243&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	FZJ	6CKI	118598721	373986840							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476032	CC1(Cc2ccc(F)cc2)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C19H16FN5O2/c1-19(10-12-2-4-13(20)5-3-12)24-17(26)15-7-6-14(18(27)25(15)19)23-16-8-9-21-11-22-16/h2-9,11H,10H2,1H3,(H,24,26)(H,21,22,23)	YAEYTHHRBQCSNR-UHFFFAOYSA-N	164257	US9669031, 3 3-(4-fluorobenzyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 3)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164257&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598810	373986842							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476033	CC1(Cc2ccc(Cl)cc2)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C19H16ClN5O2/c1-19(10-12-2-4-13(20)5-3-12)24-17(26)15-7-6-14(18(27)25(15)19)23-16-8-9-21-11-22-16/h2-9,11H,10H2,1H3,(H,24,26)(H,21,22,23)	HCWBKQWEQHJPLI-UHFFFAOYSA-N	164259	US9669031, 4 3-(4-chlorobenzyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 4)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164259&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598674	373986844							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476034	CC1(Cc2cccc(F)c2)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C19H16FN5O2/c1-19(10-12-3-2-4-13(20)9-12)24-17(26)15-6-5-14(18(27)25(15)19)23-16-7-8-21-11-22-16/h2-9,11H,10H2,1H3,(H,24,26)(H,21,22,23)	JDEUHVQFNMWMDW-UHFFFAOYSA-N	164263	US9669031, 5 3-(3-fluorobenzyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 5)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164263&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598865	373986845							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476035	O=C1NC2(CCCC2)n2c1ccc(Nc1ccncn1)c2=O	InChI=1S/C15H15N5O2/c21-13-11-4-3-10(18-12-5-8-16-9-17-12)14(22)20(11)15(19-13)6-1-2-7-15/h3-5,8-9H,1-2,6-7H2,(H,19,21)(H,16,17,18)	PIZDEEXJCJSPIZ-UHFFFAOYSA-N	164267	US9669031, 6 6&#8242;-(pyrimidin-4-ylamino)-1&#8242;H-spiro[cyclopentane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;(2&#8242;H)-dione (Cpd. No. 6)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164267&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598599	373986849							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476036	O=C1NC2(CCCC2)n2c1ccc(Nc1ccncn1)c2=O	InChI=1S/C15H15N5O2/c21-13-11-4-3-10(18-12-5-8-16-9-17-12)14(22)20(11)15(19-13)6-1-2-7-15/h3-5,8-9H,1-2,6-7H2,(H,19,21)(H,16,17,18)	PIZDEEXJCJSPIZ-UHFFFAOYSA-N	164267	US9669031, 6 6&#8242;-(pyrimidin-4-ylamino)-1&#8242;H-spiro[cyclopentane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;(2&#8242;H)-dione (Cpd. No. 6)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164267&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598599	373986849							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476037	CC1(CC(F)(F)F)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C14H12F3N5O2/c1-13(6-14(15,16)17)21-11(23)9-3-2-8(12(24)22(9)13)20-10-4-5-18-7-19-10/h2-5,7H,6H2,1H3,(H,21,23)(H,18,19,20)	XDQARUIZEWXSRW-UHFFFAOYSA-N	164268	US9669031, 7 3-methyl-6-(pyrimidin-4-ylamino)-3-(2,2,2-trifluoroethyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 7)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164268&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598991	373986850							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476038	CC1(CC(F)(F)F)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C14H12F3N5O2/c1-13(6-14(15,16)17)21-11(23)9-3-2-8(12(24)22(9)13)20-10-4-5-18-7-19-10/h2-5,7H,6H2,1H3,(H,21,23)(H,18,19,20)	XDQARUIZEWXSRW-UHFFFAOYSA-N	164268	US9669031, 7 3-methyl-6-(pyrimidin-4-ylamino)-3-(2,2,2-trifluoroethyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 7)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164268&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598991	373986850							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476039	CC(C)C1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C15H17N5O2/c1-9(2)15(3)19-13(21)11-5-4-10(14(22)20(11)15)18-12-6-7-16-8-17-12/h4-9H,1-3H3,(H,19,21)(H,16,17,18)	MTMFRAIOFPWKIH-UHFFFAOYSA-N	164269	US9669031, 8 3-isopropyl-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 8)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164269&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599055	373986851							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476040	CC(C)C1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C15H17N5O2/c1-9(2)15(3)19-13(21)11-5-4-10(14(22)20(11)15)18-12-6-7-16-8-17-12/h4-9H,1-3H3,(H,19,21)(H,16,17,18)	MTMFRAIOFPWKIH-UHFFFAOYSA-N	164269	US9669031, 8 3-isopropyl-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 8)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164269&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599055	373986851							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476041	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)C1CCCC1	InChI=1S/C17H19N5O2/c1-17(11-4-2-3-5-11)21-15(23)13-7-6-12(16(24)22(13)17)20-14-8-9-18-10-19-14/h6-11H,2-5H2,1H3,(H,21,23)(H,18,19,20)	PVFRNMLGINKVRT-UHFFFAOYSA-N	164270	US9669031, 9 3-cyclopentyl-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 9)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164270&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598705	373986852							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476042	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)C1CCCC1	InChI=1S/C17H19N5O2/c1-17(11-4-2-3-5-11)21-15(23)13-7-6-12(16(24)22(13)17)20-14-8-9-18-10-19-14/h6-11H,2-5H2,1H3,(H,21,23)(H,18,19,20)	PVFRNMLGINKVRT-UHFFFAOYSA-N	164270	US9669031, 9 3-cyclopentyl-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 9)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164270&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598705	373986852							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476043	CC1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C17H18N6O3/c1-17(2)22-15(25)11-6-5-10(16(26)23(11)17)20-12-7-13(19-8-18-12)21-14(24)9-3-4-9/h5-9H,3-4H2,1-2H3,(H,22,25)(H2,18,19,20,21,24)	PBFMGCZSHKQYOU-UHFFFAOYSA-N	164271	US9669031, 10 N-(6-((3,3-dimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 10)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164271&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598698	373986853							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476044	CC1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C17H18N6O3/c1-17(2)22-15(25)11-6-5-10(16(26)23(11)17)20-12-7-13(19-8-18-12)21-14(24)9-3-4-9/h5-9H,3-4H2,1-2H3,(H,22,25)(H2,18,19,20,21,24)	PBFMGCZSHKQYOU-UHFFFAOYSA-N	164271	US9669031, 10 N-(6-((3,3-dimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 10)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164271&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598698	373986853							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476045	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccc(F)cc1	InChI=1S/C18H14FN5O2/c1-18(11-2-4-12(19)5-3-11)23-16(25)14-7-6-13(17(26)24(14)18)22-15-8-9-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	IUWQSSGZFYFDEM-UHFFFAOYSA-N	164273	US9669031, 11 3-(4-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 11)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164273&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599004	373986855							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476046	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccc(F)cc1	InChI=1S/C18H14FN5O2/c1-18(11-2-4-12(19)5-3-11)23-16(25)14-7-6-13(17(26)24(14)18)22-15-8-9-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	IUWQSSGZFYFDEM-UHFFFAOYSA-N	164273	US9669031, 11 3-(4-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 11)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164273&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599004	373986855							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476047	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C18H14FN5O2/c1-18(11-3-2-4-12(19)9-11)23-16(25)14-6-5-13(17(26)24(14)18)22-15-7-8-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	BMCIBDDLDCNKAP-UHFFFAOYSA-N	164274	US9669031, 12 3-(3-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 12)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164274&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599059	373986856							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476048	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C18H14FN5O2/c1-18(11-3-2-4-12(19)9-11)23-16(25)14-6-5-13(17(26)24(14)18)22-15-7-8-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	BMCIBDDLDCNKAP-UHFFFAOYSA-N	164274	US9669031, 12 3-(3-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 12)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164274&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599059	373986856							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476049	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccc(Cl)cc1	InChI=1S/C18H14ClN5O2/c1-18(11-2-4-12(19)5-3-11)23-16(25)14-7-6-13(17(26)24(14)18)22-15-8-9-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	QIMGDBHWVXEGQS-UHFFFAOYSA-N	164276	US9669031, 13 3-(4-chlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 13)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164276&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598716	373986858							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476050	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccc(Cl)cc1	InChI=1S/C18H14ClN5O2/c1-18(11-2-4-12(19)5-3-11)23-16(25)14-7-6-13(17(26)24(14)18)22-15-8-9-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	QIMGDBHWVXEGQS-UHFFFAOYSA-N	164276	US9669031, 13 3-(4-chlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 13)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164276&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598716	373986858							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476051	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)C(F)(F)F	InChI=1S/C13H10F3N5O2/c1-12(13(14,15)16)20-10(22)8-3-2-7(11(23)21(8)12)19-9-4-5-17-6-18-9/h2-6H,1H3,(H,20,22)(H,17,18,19)	JKTPLWUWZRKRRA-UHFFFAOYSA-N	164278	US9669031, 14 3-methyl-6-(pyrimidin-4-ylamino)-3-(trifluoromethyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 14)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164278&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598584	373986860							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476052	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)C(F)(F)F	InChI=1S/C13H10F3N5O2/c1-12(13(14,15)16)20-10(22)8-3-2-7(11(23)21(8)12)19-9-4-5-17-6-18-9/h2-6H,1H3,(H,20,22)(H,17,18,19)	JKTPLWUWZRKRRA-UHFFFAOYSA-N	164278	US9669031, 14 3-methyl-6-(pyrimidin-4-ylamino)-3-(trifluoromethyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 14)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164278&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598584	373986860							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476053	CC1(CN2C(=O)c3ccccc3C2=O)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C21H16N6O4/c1-21(10-26-18(29)12-4-2-3-5-13(12)19(26)30)25-17(28)15-7-6-14(20(31)27(15)21)24-16-8-9-22-11-23-16/h2-9,11H,10H2,1H3,(H,25,28)(H,22,23,24)	VTIZTSIEPWADNJ-UHFFFAOYSA-N	164279	US9669031, 15 3-(aminomethyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 15)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164279&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599106	373986861							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476054	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccsc1	InChI=1S/C16H13N5O2S/c1-16(10-5-7-24-8-10)20-14(22)12-3-2-11(15(23)21(12)16)19-13-4-6-17-9-18-13/h2-9H,1H3,(H,20,22)(H,17,18,19)	MDHMVBOHQWAVQR-UHFFFAOYSA-N	164280	US9669031, 16 3-methyl-6-(pyrimidin-4-ylamino)-3-(thiophen-3-yl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 16)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164280&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598971	373986862							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476055	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccsc1	InChI=1S/C16H13N5O2S/c1-16(10-5-7-24-8-10)20-14(22)12-3-2-11(15(23)21(12)16)19-13-4-6-17-9-18-13/h2-9H,1H3,(H,20,22)(H,17,18,19)	MDHMVBOHQWAVQR-UHFFFAOYSA-N	164280	US9669031, 16 3-methyl-6-(pyrimidin-4-ylamino)-3-(thiophen-3-yl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 16)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164280&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598971	373986862							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476056	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cscn1	InChI=1S/C15H12N6O2S/c1-15(11-6-24-8-18-11)20-13(22)10-3-2-9(14(23)21(10)15)19-12-4-5-16-7-17-12/h2-8H,1H3,(H,20,22)(H,16,17,19)	SPCGKBTWSYAQCO-UHFFFAOYSA-N	164281	US9669031, 17 3-methyl-6-(pyrimidin-4-ylamino)-3-(thiazol-4-yl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 17)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164281&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598609	373986863							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476057	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C18H14ClN5O2/c1-18(11-3-2-4-12(19)9-11)23-16(25)14-6-5-13(17(26)24(14)18)22-15-7-8-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	WYZLXIGWRWGIKE-UHFFFAOYSA-N	164590	US9669031, 18 3-(3-chlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 18)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164590&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598769	373986948							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476058	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C18H14ClN5O2/c1-18(11-3-2-4-12(19)9-11)23-16(25)14-6-5-13(17(26)24(14)18)22-15-7-8-20-10-21-15/h2-10H,1H3,(H,23,25)(H,20,21,22)	WYZLXIGWRWGIKE-UHFFFAOYSA-N	164590	US9669031, 18 3-(3-chlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 18)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164590&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598769	373986948							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476059	CC1(Cc2cccc(Cl)c2)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C19H16ClN5O2/c1-19(10-12-3-2-4-13(20)9-12)24-17(26)15-6-5-14(18(27)25(15)19)23-16-7-8-21-11-22-16/h2-9,11H,10H2,1H3,(H,24,26)(H,21,22,23)	FHIVPUSFCLAIJH-UHFFFAOYSA-N	164598	US9669031, 19 3-(3-chlorobenzyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 19)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164598&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598662	373986949							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476060	CC(C)(C)OC(=O)N1CCCC2(C1)NC(=O)c1ccc(Nc3ccncn3)c(=O)n21	InChI=1S/C20H24N6O4/c1-19(2,3)30-18(29)25-10-4-8-20(11-25)24-16(27)14-6-5-13(17(28)26(14)20)23-15-7-9-21-12-22-15/h5-7,9,12H,4,8,10-11H2,1-3H3,(H,24,27)(H,21,22,23)	XPWKCZAAGOHOKA-UHFFFAOYSA-N	164599	US9669031, 20 6-(pyrimidin-4-ylamino)-1H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5(2H)-dione (Cpd. No. 20)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164599&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598736	373986950							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476061	CC(C)(C)OC(=O)N1CCCC2(C1)NC(=O)c1ccc(Nc3ccncn3)c(=O)n21	InChI=1S/C20H24N6O4/c1-19(2,3)30-18(29)25-10-4-8-20(11-25)24-16(27)14-6-5-13(17(28)26(14)20)23-15-7-9-21-12-22-15/h5-7,9,12H,4,8,10-11H2,1-3H3,(H,24,27)(H,21,22,23)	XPWKCZAAGOHOKA-UHFFFAOYSA-N	164599	US9669031, 20 6-(pyrimidin-4-ylamino)-1H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5(2H)-dione (Cpd. No. 20)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164599&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598736	373986950							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476062	O=C(Nc1cc(Nc2ccc3C(=O)NC4(CCCC4)n3c2=O)ncn1)C1CC1	InChI=1S/C19H20N6O3/c26-16(11-3-4-11)23-15-9-14(20-10-21-15)22-12-5-6-13-17(27)24-19(7-1-2-8-19)25(13)18(12)28/h5-6,9-11H,1-4,7-8H2,(H,24,27)(H2,20,21,22,23,26)	MPKGGPLLAPUWLX-UHFFFAOYSA-N	164600	US9669031, 21 N-[6-[(1,5-dioxospiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 21)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164600&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598723	373986951							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476063	O=C(Nc1cc(Nc2ccc3C(=O)NC4(CCCC4)n3c2=O)ncn1)C1CC1	InChI=1S/C19H20N6O3/c26-16(11-3-4-11)23-15-9-14(20-10-21-15)22-12-5-6-13-17(27)24-19(7-1-2-8-19)25(13)18(12)28/h5-6,9-11H,1-4,7-8H2,(H,24,27)(H2,20,21,22,23,26)	MPKGGPLLAPUWLX-UHFFFAOYSA-N	164600	US9669031, 21 N-[6-[(1,5-dioxospiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 21)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164600&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598723	373986951							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476064	CC1(CC(F)(F)F)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C18H17F3N6O3/c1-17(7-18(19,20)21)26-15(29)11-5-4-10(16(30)27(11)17)24-12-6-13(23-8-22-12)25-14(28)9-2-3-9/h4-6,8-9H,2-3,7H2,1H3,(H,26,29)(H2,22,23,24,25,28)	BQLLCJSAYOZGIF-UHFFFAOYSA-N	164607	US9669031, 22 N-(6-((3-methyl-1,5-dioxo-3-(2,2,2-trifluoroethyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 22)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164607&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598803	373986952							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476065	CC1(CC(F)(F)F)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C18H17F3N6O3/c1-17(7-18(19,20)21)26-15(29)11-5-4-10(16(30)27(11)17)24-12-6-13(23-8-22-12)25-14(28)9-2-3-9/h4-6,8-9H,2-3,7H2,1H3,(H,26,29)(H2,22,23,24,25,28)	BQLLCJSAYOZGIF-UHFFFAOYSA-N	164607	US9669031, 22 N-(6-((3-methyl-1,5-dioxo-3-(2,2,2-trifluoroethyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 22)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164607&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598803	373986952							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476066	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C1CCCC1	InChI=1S/C21H24N6O3/c1-21(13-4-2-3-5-13)26-19(29)15-9-8-14(20(30)27(15)21)24-16-10-17(23-11-22-16)25-18(28)12-6-7-12/h8-13H,2-7H2,1H3,(H,26,29)(H2,22,23,24,25,28)	WYSSCWVPJCWZCU-UHFFFAOYSA-N	164608	US9669031, 118 6-[(6-aminopyrimidin-4-yl)amino]-3-cyclopentyl-3-methyl-1,5-dioxo-imidazo[1,5-a]pyridine-2-carbonitrile (Cpd. No. 118)::US9669031, 23 N-[6-[(3-cyclopentyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 23)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164608&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598558	373986953							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476067	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C1CCCC1	InChI=1S/C21H24N6O3/c1-21(13-4-2-3-5-13)26-19(29)15-9-8-14(20(30)27(15)21)24-16-10-17(23-11-22-16)25-18(28)12-6-7-12/h8-13H,2-7H2,1H3,(H,26,29)(H2,22,23,24,25,28)	WYSSCWVPJCWZCU-UHFFFAOYSA-N	164608	US9669031, 118 6-[(6-aminopyrimidin-4-yl)amino]-3-cyclopentyl-3-methyl-1,5-dioxo-imidazo[1,5-a]pyridine-2-carbonitrile (Cpd. No. 118)::US9669031, 23 N-[6-[(3-cyclopentyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 23)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164608&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598558	373986953							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476068	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C17H15F3N6O3/c1-16(17(18,19)20)25-14(28)10-5-4-9(15(29)26(10)16)23-11-6-12(22-7-21-11)24-13(27)8-2-3-8/h4-8H,2-3H2,1H3,(H,25,28)(H2,21,22,23,24,27)	BWTQXRPICXZKMG-UHFFFAOYSA-N	164609	US9669031, 24 N-[6-[[3-methyl-1,5-dioxo-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 24)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164609&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598912	373986954							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476069	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C17H15F3N6O3/c1-16(17(18,19)20)25-14(28)10-5-4-9(15(29)26(10)16)23-11-6-12(22-7-21-11)24-13(27)8-2-3-8/h4-8H,2-3H2,1H3,(H,25,28)(H2,21,22,23,24,27)	BWTQXRPICXZKMG-UHFFFAOYSA-N	164609	US9669031, 24 N-[6-[[3-methyl-1,5-dioxo-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 24)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164609&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598912	373986954							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476070	CN(CC1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)C(=O)OC(C)(C)C	InChI=1S/C19H24N6O4/c1-18(2,3)29-17(28)24(5)10-19(4)23-15(26)13-7-6-12(16(27)25(13)19)22-14-8-9-20-11-21-14/h6-9,11H,10H2,1-5H3,(H,23,26)(H,20,21,22)	JJLBMZMLQJTVQG-UHFFFAOYSA-N	164610	US9669031, 25 3-methyl-3-((methylamino)methyl)-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 25)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164610&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598793	373986955							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476071	O=C(OCc1ccccc1)N1CCC2(C1)NC(=O)c1ccc(Nc3ccncn3)c(=O)n21	InChI=1S/C22H20N6O4/c29-19-17-7-6-16(25-18-8-10-23-14-24-18)20(30)28(17)22(26-19)9-11-27(13-22)21(31)32-12-15-4-2-1-3-5-15/h1-8,10,14H,9,11-13H2,(H,26,29)(H,23,24,25)	ISYWVZXBVXGDIR-UHFFFAOYSA-N	164611	US9669031, 26 6-(pyrimidin-4-ylamino)-1H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-pyrrolidine]-1,5(2H)-dione (Cpd. No. 26)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164611&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598903	373986956							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476072	O=C(OCc1ccccc1)N1CCC2(C1)NC(=O)c1ccc(Nc3ccncn3)c(=O)n21	InChI=1S/C22H20N6O4/c29-19-17-7-6-16(25-18-8-10-23-14-24-18)20(30)28(17)22(26-19)9-11-27(13-22)21(31)32-12-15-4-2-1-3-5-15/h1-8,10,14H,9,11-13H2,(H,26,29)(H,23,24,25)	ISYWVZXBVXGDIR-UHFFFAOYSA-N	164611	US9669031, 26 6-(pyrimidin-4-ylamino)-1H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-pyrrolidine]-1,5(2H)-dione (Cpd. No. 26)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164611&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598903	373986956							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476073	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cc(F)cc(F)c1	InChI=1S/C18H13F2N5O2/c1-18(10-6-11(19)8-12(20)7-10)24-16(26)14-3-2-13(17(27)25(14)18)23-15-4-5-21-9-22-15/h2-9H,1H3,(H,24,26)(H,21,22,23)	KQXTVRJPONHNFY-UHFFFAOYSA-N	164615	US9669031, 27 3-(3,5-difluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 27)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164615&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598580	373986957							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476074	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cc(F)cc(F)c1	InChI=1S/C18H13F2N5O2/c1-18(10-6-11(19)8-12(20)7-10)24-16(26)14-3-2-13(17(27)25(14)18)23-15-4-5-21-9-22-15/h2-9H,1H3,(H,24,26)(H,21,22,23)	KQXTVRJPONHNFY-UHFFFAOYSA-N	164615	US9669031, 27 3-(3,5-difluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 27)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164615&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598580	373986957							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476075	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cc(F)cc(Cl)c1	InChI=1S/C18H13ClFN5O2/c1-18(10-6-11(19)8-12(20)7-10)24-16(26)14-3-2-13(17(27)25(14)18)23-15-4-5-21-9-22-15/h2-9H,1H3,(H,24,26)(H,21,22,23)	DBLJVNGTXRPKMS-UHFFFAOYSA-N	168130	US9669031, 28 3-(3-chloro-5-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 28)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168130&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599074	373986958							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476076	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cc(F)cc(Cl)c1	InChI=1S/C18H13ClFN5O2/c1-18(10-6-11(19)8-12(20)7-10)24-16(26)14-3-2-13(17(27)25(14)18)23-15-4-5-21-9-22-15/h2-9H,1H3,(H,24,26)(H,21,22,23)	DBLJVNGTXRPKMS-UHFFFAOYSA-N	168130	US9669031, 28 3-(3-chloro-5-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 28)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168130&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599074	373986958							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476077	CC(C)C1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C19H22N6O3/c1-10(2)19(3)24-17(27)13-7-6-12(18(28)25(13)19)22-14-8-15(21-9-20-14)23-16(26)11-4-5-11/h6-11H,4-5H2,1-3H3,(H,24,27)(H2,20,21,22,23,26)	YKIHKWBWAZGDHU-UHFFFAOYSA-N	168131	US9669031, 29 N-[6-[(3-isopropyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 29)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168131&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598957	373986959							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476078	CC(C)C1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C19H22N6O3/c1-10(2)19(3)24-17(27)13-7-6-12(18(28)25(13)19)22-14-8-15(21-9-20-14)23-16(26)11-4-5-11/h6-11H,4-5H2,1-3H3,(H,24,27)(H2,20,21,22,23,26)	YKIHKWBWAZGDHU-UHFFFAOYSA-N	168131	US9669031, 29 N-[6-[(3-isopropyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 29)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168131&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598957	373986959							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476079	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C22H19FN6O3/c1-22(13-3-2-4-14(23)9-13)28-20(31)16-8-7-15(21(32)29(16)22)26-17-10-18(25-11-24-17)27-19(30)12-5-6-12/h2-4,7-12H,5-6H2,1H3,(H,28,31)(H2,24,25,26,27,30)	FQGCYYMRDLPKSG-UHFFFAOYSA-N	168140	US9669031, 30 N-[6-[[3-(3-fluorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 30)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168140&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599141	373986960							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476080	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C22H19FN6O3/c1-22(13-3-2-4-14(23)9-13)28-20(31)16-8-7-15(21(32)29(16)22)26-17-10-18(25-11-24-17)27-19(30)12-5-6-12/h2-4,7-12H,5-6H2,1H3,(H,28,31)(H2,24,25,26,27,30)	FQGCYYMRDLPKSG-UHFFFAOYSA-N	168140	US9669031, 30 N-[6-[[3-(3-fluorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 30)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168140&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599141	373986960							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476081	CC1(NC(=O)c2ccc(Nc3cc(\C=C\C4CC4)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C18H16F3N5O2/c1-17(18(19,20)21)25-15(27)13-7-6-12(16(28)26(13)17)24-14-8-11(22-9-23-14)5-4-10-2-3-10/h4-10H,2-3H2,1H3,(H,25,27)(H,22,23,24)/b5-4+	FGFUUBCEERIDBQ-SNAWJCMRSA-N	168200	US9669031, 31 6-[[6-[(E)-2-cyclopropylvinyl]pyrimidin-4-yl]amino]-3-methyl-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 31)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168200&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598607	373986963							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476082	CC1(NC(=O)c2ccc(Nc3cc(\C=C\C4CC4)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C18H16F3N5O2/c1-17(18(19,20)21)25-15(27)13-7-6-12(16(28)26(13)17)24-14-8-11(22-9-23-14)5-4-10-2-3-10/h4-10H,2-3H2,1H3,(H,25,27)(H,22,23,24)/b5-4+	FGFUUBCEERIDBQ-SNAWJCMRSA-N	168200	US9669031, 31 6-[[6-[(E)-2-cyclopropylvinyl]pyrimidin-4-yl]amino]-3-methyl-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 31)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168200&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598607	373986963							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476083	CC1(C)NC(=O)c2ccc(-n3ccc4cncnc34)c(=O)n12	InChI=1S/C15H13N5O2/c1-15(2)18-13(21)10-3-4-11(14(22)20(10)15)19-6-5-9-7-16-8-17-12(9)19/h3-8H,1-2H3,(H,18,21)	IEZSRTFZJXWJSC-UHFFFAOYSA-N	168201	US9669031, 32 3,3-dimethyl-6-(7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 32)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168201&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598959	373986964							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476084	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cc(Cl)cc(Cl)c1	InChI=1S/C18H13Cl2N5O2/c1-18(10-6-11(19)8-12(20)7-10)24-16(26)14-3-2-13(17(27)25(14)18)23-15-4-5-21-9-22-15/h2-9H,1H3,(H,24,26)(H,21,22,23)	KLPWXPHBHLDCCS-UHFFFAOYSA-N	168202	US9669031, 33 3-(3,5-dichlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 33)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168202&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598690	373986965							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476085	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1cc(Cl)cc(Cl)c1	InChI=1S/C18H13Cl2N5O2/c1-18(10-6-11(19)8-12(20)7-10)24-16(26)14-3-2-13(17(27)25(14)18)23-15-4-5-21-9-22-15/h2-9H,1H3,(H,24,26)(H,21,22,23)	KLPWXPHBHLDCCS-UHFFFAOYSA-N	168202	US9669031, 33 3-(3,5-dichlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 33)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168202&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598690	373986965							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476086	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccccn1	InChI=1S/C17H14N6O2/c1-17(13-4-2-3-8-19-13)22-15(24)12-6-5-11(16(25)23(12)17)21-14-7-9-18-10-20-14/h2-10H,1H3,(H,22,24)(H,18,20,21)	GVYZOWDBQXKJDR-UHFFFAOYSA-N	168203	US9669031, 34 3-methyl-3-(pyridin-2-yl)-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 34)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168203&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598882	373986966							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476087	CC1(NC(=O)c2ccc(Nc3ccncn3)c(=O)n12)c1ccccn1	InChI=1S/C17H14N6O2/c1-17(13-4-2-3-8-19-13)22-15(24)12-6-5-11(16(25)23(12)17)21-14-7-9-18-10-20-14/h2-10H,1H3,(H,22,24)(H,18,20,21)	GVYZOWDBQXKJDR-UHFFFAOYSA-N	168203	US9669031, 34 3-methyl-3-(pyridin-2-yl)-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 34)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168203&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598882	373986966							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476088	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)C(F)(F)F	InChI=1S/C13H9ClF3N5O2/c1-12(13(15,16)17)21-10(23)9-6(14)4-7(11(24)22(9)12)20-8-2-3-18-5-19-8/h2-5H,1H3,(H,21,23)(H,18,19,20)	PCVWCCALBZINES-UHFFFAOYSA-N	168204	US9669031, 35 8-chloro-3-methyl-6-(pyrimidin-4-ylamino)-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 35)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168204&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598597	373986967							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476089	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)C(F)(F)F	InChI=1S/C13H9ClF3N5O2/c1-12(13(15,16)17)21-10(23)9-6(14)4-7(11(24)22(9)12)20-8-2-3-18-5-19-8/h2-5H,1H3,(H,21,23)(H,18,19,20)	PCVWCCALBZINES-UHFFFAOYSA-N	168204	US9669031, 35 8-chloro-3-methyl-6-(pyrimidin-4-ylamino)-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 35)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168204&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598597	373986967							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476090	CC1(C)CCCC11NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H19N5O2/c1-16(2)7-3-8-17(16)21-14(23)12-5-4-11(15(24)22(12)17)20-13-6-9-18-10-19-13/h4-6,9-10H,3,7-8H2,1-2H3,(H,21,23)(H,18,19,20)	VEEXATBXYUTWTO-UHFFFAOYSA-N	168205	US9669031, 36 2&#8242;,2&#8242;-dimethyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione (Cpd. No. 36)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168205&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598843	373986968							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476091	CC1(C)CCCC11NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H19N5O2/c1-16(2)7-3-8-17(16)21-14(23)12-5-4-11(15(24)22(12)17)20-13-6-9-18-10-19-13/h4-6,9-10H,3,7-8H2,1-2H3,(H,21,23)(H,18,19,20)	VEEXATBXYUTWTO-UHFFFAOYSA-N	168205	US9669031, 36 2&#8242;,2&#8242;-dimethyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione (Cpd. No. 36)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168205&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598843	373986968							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476092	CC1(NC(=O)c2ccc(Nc3ncnc4[nH]c(cc34)C3CC3)c(=O)n12)C(F)(F)F			168206	US9669031, 37 6-[(8-cyclopropyl-9H-purin-6-yl)amino]-3-methyl-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 37)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168206&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			122659712	373986969							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476093	CC1(NC(=O)c2ccc(Nc3ncnc4[nH]c(cc34)C3CC3)c(=O)n12)C(F)(F)F			168206	US9669031, 37 6-[(8-cyclopropyl-9H-purin-6-yl)amino]-3-methyl-3-(trifluoromethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 37)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168206	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168206&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			122659712	373986969							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476094	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCC1	InChI=1S/C19H19ClN6O3/c20-11-7-12(18(29)26-15(11)17(28)25-19(26)5-1-2-6-19)23-13-8-14(22-9-21-13)24-16(27)10-3-4-10/h7-10H,1-6H2,(H,25,28)(H2,21,22,23,24,27)	QGCZTCRYEXQLPN-UHFFFAOYSA-N	168207	US9669031, 38 N-[6-[(8-chloro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 38)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168207&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599028	373986970							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476095	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCC1	InChI=1S/C19H19ClN6O3/c20-11-7-12(18(29)26-15(11)17(28)25-19(26)5-1-2-6-19)23-13-8-14(22-9-21-13)24-16(27)10-3-4-10/h7-10H,1-6H2,(H,25,28)(H2,21,22,23,24,27)	QGCZTCRYEXQLPN-UHFFFAOYSA-N	168207	US9669031, 38 N-[6-[(8-chloro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 38)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168207&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599028	373986970							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476096	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCC1	InChI=1S/C15H14ClN5O2/c16-9-7-10(19-11-3-6-17-8-18-11)14(23)21-12(9)13(22)20-15(21)4-1-2-5-15/h3,6-8H,1-2,4-5H2,(H,20,22)(H,17,18,19)	ZXXGSXICBBXGRT-UHFFFAOYSA-N	168208	US9669031, 39 8&#8242;-chloro-6&#8242;-(pyrimidin-4-ylamino)-2&#8242;H-spiro[cyclopentane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 39)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168208&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599139	373986971							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476097	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCC1	InChI=1S/C15H14ClN5O2/c16-9-7-10(19-11-3-6-17-8-18-11)14(23)21-12(9)13(22)20-15(21)4-1-2-5-15/h3,6-8H,1-2,4-5H2,(H,20,22)(H,17,18,19)	ZXXGSXICBBXGRT-UHFFFAOYSA-N	168208	US9669031, 39 8&#8242;-chloro-6&#8242;-(pyrimidin-4-ylamino)-2&#8242;H-spiro[cyclopentane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 39)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168208&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599139	373986971							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476098	CC1(C)NC(=O)c2ccc(N3CCc4cncnc34)c(=O)n12	InChI=1S/C15H15N5O2/c1-15(2)18-13(21)10-3-4-11(14(22)20(10)15)19-6-5-9-7-16-8-17-12(9)19/h3-4,7-8H,5-6H2,1-2H3,(H,18,21)	UKOPCQWEKFHXDI-UHFFFAOYSA-N	168209	US9669031, 40 3,3-dimethyl-6-(5H-pyrrolo[2,3-d]pyrimidin-7(6H)-yl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 40)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168209&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598868	373986972							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476099	CC1(CCN2C(=O)c3ccccc3C2=O)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C22H18N6O4/c1-22(9-11-27-19(30)13-4-2-3-5-14(13)20(27)31)26-18(29)16-7-6-15(21(32)28(16)22)25-17-8-10-23-12-24-17/h2-8,10,12H,9,11H2,1H3,(H,26,29)(H,23,24,25)	CWQSPWWPLXOCGX-UHFFFAOYSA-N	168210	US9669031, 41 3-(2-aminoethyl)-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 41)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168210&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598670	373986973							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476100	CC1(CCN2C(=O)c3ccccc3C2=O)NC(=O)c2ccc(Nc3ccncn3)c(=O)n12	InChI=1S/C22H18N6O4/c1-22(9-11-27-19(30)13-4-2-3-5-14(13)20(27)31)26-18(29)16-7-6-15(21(32)28(16)22)25-17-8-10-23-12-24-17/h2-8,10,12H,9,11H2,1H3,(H,26,29)(H,23,24,25)	CWQSPWWPLXOCGX-UHFFFAOYSA-N	168210	US9669031, 41 3-(2-aminoethyl)-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 41)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168210	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168210&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598670	373986973							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476101	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C1CCCC1	InChI=1S/C21H23ClN6O3/c1-21(12-4-2-3-5-12)27-19(30)17-13(22)8-14(20(31)28(17)21)25-15-9-16(24-10-23-15)26-18(29)11-6-7-11/h8-12H,2-7H2,1H3,(H,27,30)(H2,23,24,25,26,29)	WRGPPEWTBBOCMV-UHFFFAOYSA-N	168211	US9669031, 42 N-[6-[(8-chloro-3-cyclopentyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 42)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168211&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599096	373986974							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476102	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C1CCCC1	InChI=1S/C21H23ClN6O3/c1-21(12-4-2-3-5-12)27-19(30)17-13(22)8-14(20(31)28(17)21)25-15-9-16(24-10-23-15)26-18(29)11-6-7-11/h8-12H,2-7H2,1H3,(H,27,30)(H2,23,24,25,26,29)	WRGPPEWTBBOCMV-UHFFFAOYSA-N	168211	US9669031, 42 N-[6-[(8-chloro-3-cyclopentyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 42)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168211	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168211&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599096	373986974							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476103	CC1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C17H17ClN6O3/c1-17(2)23-15(26)13-9(18)5-10(16(27)24(13)17)21-11-6-12(20-7-19-11)22-14(25)8-3-4-8/h5-8H,3-4H2,1-2H3,(H,23,26)(H2,19,20,21,22,25)	MSMODVCLZGRBDS-UHFFFAOYSA-N	168212	US9669031, 43 N-[6-[(8-chloro-3,3-dimethyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 43)::US9669031, 88 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3,3-dimethyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 88)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168212&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598805	373986975							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476104	CC1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C17H17ClN6O3/c1-17(2)23-15(26)13-9(18)5-10(16(27)24(13)17)21-11-6-12(20-7-19-11)22-14(25)8-3-4-8/h5-8H,3-4H2,1-2H3,(H,23,26)(H2,19,20,21,22,25)	MSMODVCLZGRBDS-UHFFFAOYSA-N	168212	US9669031, 43 N-[6-[(8-chloro-3,3-dimethyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 43)::US9669031, 88 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3,3-dimethyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 88)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168212&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598805	373986975							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476105	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCC1	InChI=1S/C18H17ClN6O3/c19-10-6-11(17(28)25-14(10)16(27)24-18(25)4-1-5-18)22-12-7-13(21-8-20-12)23-15(26)9-2-3-9/h6-9H,1-5H2,(H,24,27)(H2,20,21,22,23,26)	QEXNXVBBXJXJMK-UHFFFAOYSA-N	168213	US9669031, 44 N-(6-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclobutane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 44)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168213&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598627	373986976							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476106	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCC1	InChI=1S/C18H17ClN6O3/c19-10-6-11(17(28)25-14(10)16(27)24-18(25)4-1-5-18)22-12-7-13(21-8-20-12)23-15(26)9-2-3-9/h6-9H,1-5H2,(H,24,27)(H2,20,21,22,23,26)	QEXNXVBBXJXJMK-UHFFFAOYSA-N	168213	US9669031, 44 N-(6-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclobutane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 44)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168213&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598627	373986976							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476107	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C20H21ClN6O3/c21-12-8-13(24-14-9-15(23-10-22-14)25-17(28)11-4-5-11)19(30)27-16(12)18(29)26-20(27)6-2-1-3-7-20/h8-11H,1-7H2,(H,26,29)(H2,22,23,24,25,28)	RLDAVKBTPHGEED-UHFFFAOYSA-N	168214	US9669031, 207 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-(hydroxymethyl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 207)::US9669031, 45 N-(6-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 45)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168214&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598693	373986977							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476108	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C20H21ClN6O3/c21-12-8-13(24-14-9-15(23-10-22-14)25-17(28)11-4-5-11)19(30)27-16(12)18(29)26-20(27)6-2-1-3-7-20/h8-11H,1-7H2,(H,26,29)(H2,22,23,24,25,28)	RLDAVKBTPHGEED-UHFFFAOYSA-N	168214	US9669031, 207 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-(hydroxymethyl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 207)::US9669031, 45 N-(6-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 45)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168214&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598693	373986977							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476109	CC1(CC(F)(F)F)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C18H16ClF3N6O3/c1-17(6-18(20,21)22)27-15(30)13-9(19)4-10(16(31)28(13)17)25-11-5-12(24-7-23-11)26-14(29)8-2-3-8/h4-5,7-8H,2-3,6H2,1H3,(H,27,30)(H2,23,24,25,26,29)	ORHFBHIRGIWNAH-UHFFFAOYSA-N	168215	US9669031, 46 N-[6-[[8-chloro-3-methyl-1,5-dioxo-3-(2,2,2-trifluoroethyl)-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 46)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168215&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598756	373986978							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476110	CC1(CC(F)(F)F)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C18H16ClF3N6O3/c1-17(6-18(20,21)22)27-15(30)13-9(19)4-10(16(31)28(13)17)25-11-5-12(24-7-23-11)26-14(29)8-2-3-8/h4-5,7-8H,2-3,6H2,1H3,(H,27,30)(H2,23,24,25,26,29)	ORHFBHIRGIWNAH-UHFFFAOYSA-N	168215	US9669031, 46 N-[6-[[8-chloro-3-methyl-1,5-dioxo-3-(2,2,2-trifluoroethyl)-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 46)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168215&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598756	373986978							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476111	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476112	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476113	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)C1CCCC1	InChI=1S/C17H18ClN5O2/c1-17(10-4-2-3-5-10)22-15(24)14-11(18)8-12(16(25)23(14)17)21-13-6-7-19-9-20-13/h6-10H,2-5H2,1H3,(H,22,24)(H,19,20,21)	KEMNQVUQQLPJPY-UHFFFAOYSA-N	168217	US9669031, 48 8-chloro-3-cyclopentyl-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 48)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168217&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598924	373986980							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476114	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)C1CCCC1	InChI=1S/C17H18ClN5O2/c1-17(10-4-2-3-5-10)22-15(24)14-11(18)8-12(16(25)23(14)17)21-13-6-7-19-9-20-13/h6-10H,2-5H2,1H3,(H,22,24)(H,19,20,21)	KEMNQVUQQLPJPY-UHFFFAOYSA-N	168217	US9669031, 48 8-chloro-3-cyclopentyl-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 48)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168217	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168217&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598924	373986980							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476115	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C17H14ClF3N6O3/c1-16(17(19,20)21)26-14(29)12-8(18)4-9(15(30)27(12)16)24-10-5-11(23-6-22-10)25-13(28)7-2-3-7/h4-7H,2-3H2,1H3,(H,26,29)(H2,22,23,24,25,28)	OKFHPNCIMLAJFM-UHFFFAOYSA-N	168220	US9669031, 49 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(trifluoromethyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 49)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168220&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599076	373986981							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476116	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C17H14ClF3N6O3/c1-16(17(19,20)21)26-14(29)12-8(18)4-9(15(30)27(12)16)24-10-5-11(23-6-22-10)25-13(28)7-2-3-7/h4-7H,2-3H2,1H3,(H,26,29)(H2,22,23,24,25,28)	OKFHPNCIMLAJFM-UHFFFAOYSA-N	168220	US9669031, 49 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(trifluoromethyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 49)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168220&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599076	373986981							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476117	FC1(F)CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C20H19ClF2N6O3/c21-11-7-12(26-13-8-14(25-9-24-13)27-16(30)10-1-2-10)18(32)29-15(11)17(31)28-20(29)5-3-19(22,23)4-6-20/h7-10H,1-6H2,(H,28,31)(H2,24,25,26,27,30)	WUCBMAZIUGCYRG-UHFFFAOYSA-N	168221	US9669031, 50 N-[6-[(8-chloro-4&#8242;,4&#8242;-difluoro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 50)::US9669031, 99 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-4&#8242;,4&#8242;-difluoro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 99)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168221&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598601	373986982							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476118	FC1(F)CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C20H19ClF2N6O3/c21-11-7-12(26-13-8-14(25-9-24-13)27-16(30)10-1-2-10)18(32)29-15(11)17(31)28-20(29)5-3-19(22,23)4-6-20/h7-10H,1-6H2,(H,28,31)(H2,24,25,26,27,30)	WUCBMAZIUGCYRG-UHFFFAOYSA-N	168221	US9669031, 50 N-[6-[(8-chloro-4&#8242;,4&#8242;-difluoro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 50)::US9669031, 99 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-4&#8242;,4&#8242;-difluoro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 99)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168221&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598601	373986982							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476119	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C22H18Cl2N6O3/c1-22(12-3-2-4-13(23)7-12)29-20(32)18-14(24)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	RZKFMYXHNVBJJV-UHFFFAOYSA-N	168222	US9669031, 51 N-[6-[[8-chloro-3-(3-chlorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 51)::US9669031, 93 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-chlorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 93)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168222&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599023	373986983							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476120	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C22H18Cl2N6O3/c1-22(12-3-2-4-13(23)7-12)29-20(32)18-14(24)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	RZKFMYXHNVBJJV-UHFFFAOYSA-N	168222	US9669031, 51 N-[6-[[8-chloro-3-(3-chlorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 51)::US9669031, 93 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-chlorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 93)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168222&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599023	373986983							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476121	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C22H18ClFN6O3/c1-22(12-3-2-4-13(24)7-12)29-20(32)18-14(23)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	BTPOGDUCUHHPDU-UHFFFAOYSA-N	168223	US9669031, 52 N-[6-[[8-chloro-3-(3-fluorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 52)::US9669031, 87 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-fluorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 87)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168223&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598561	373986984							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476122	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C22H18ClFN6O3/c1-22(12-3-2-4-13(24)7-12)29-20(32)18-14(23)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	BTPOGDUCUHHPDU-UHFFFAOYSA-N	168223	US9669031, 52 N-[6-[[8-chloro-3-(3-fluorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 52)::US9669031, 87 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-fluorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 87)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168223&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598561	373986984							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476123	Clc1ccc2C(=O)NC3(CCC[C@@H](C3)N3C(=O)c4ccccc4C3=O)n2c1=O	InChI=1S/C20H16ClN3O4/c21-14-7-8-15-16(25)22-20(24(15)19(14)28)9-3-4-11(10-20)23-17(26)12-5-1-2-6-13(12)18(23)27/h1-2,5-8,11H,3-4,9-10H2,(H,22,25)/t11-,20?/m0/s1	GAWJEBCHHUPVEO-ZOZMEPSFSA-N	168224	US9669031, 53 (3&#8242;S)-3&#8242;-amino-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 53)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168224&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598867	373986985							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476124	Clc1ccc2C(=O)NC3(CCC[C@@H](C3)N3C(=O)c4ccccc4C3=O)n2c1=O	InChI=1S/C20H16ClN3O4/c21-14-7-8-15-16(25)22-20(24(15)19(14)28)9-3-4-11(10-20)23-17(26)12-5-1-2-6-13(12)18(23)27/h1-2,5-8,11H,3-4,9-10H2,(H,22,25)/t11-,20?/m0/s1	GAWJEBCHHUPVEO-ZOZMEPSFSA-N	168224	US9669031, 53 (3&#8242;S)-3&#8242;-amino-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 53)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168224&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598867	373986985							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476125	CC(C)(C)OC(=O)N1CCCC2(C1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C20H23ClN6O4/c1-19(2,3)31-18(30)26-8-4-6-20(10-26)25-16(28)15-12(21)9-13(17(29)27(15)20)24-14-5-7-22-11-23-14/h5,7,9,11H,4,6,8,10H2,1-3H3,(H,25,28)(H,22,23,24)	INOAKEXRSQGTLU-UHFFFAOYSA-N	168225	US9669031, 54 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 54)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168225&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598812	373986986							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476126	CC(C)(C)OC(=O)N1CCCC2(C1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C20H23ClN6O4/c1-19(2,3)31-18(30)26-8-4-6-20(10-26)25-16(28)15-12(21)9-13(17(29)27(15)20)24-14-5-7-22-11-23-14/h5,7,9,11H,4,6,8,10H2,1-3H3,(H,25,28)(H,22,23,24)	INOAKEXRSQGTLU-UHFFFAOYSA-N	168225	US9669031, 54 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 54)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168225&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598812	373986986							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476127	CC1(CC(F)(F)F)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C14H11ClF3N5O2/c1-13(5-14(16,17)18)22-11(24)10-7(15)4-8(12(25)23(10)13)21-9-2-3-19-6-20-9/h2-4,6H,5H2,1H3,(H,22,24)(H,19,20,21)	UBENEGKGQZFLRG-UHFFFAOYSA-N	168226	US9669031, 55 8-chloro-3-methyl-6-(pyrimidin-4-ylamino)-3-(2,2,2-trifluoroethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 55)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168226&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598672	373986987							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476128	CC1(CC(F)(F)F)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C14H11ClF3N5O2/c1-13(5-14(16,17)18)22-11(24)10-7(15)4-8(12(25)23(10)13)21-9-2-3-19-6-20-9/h2-4,6H,5H2,1H3,(H,22,24)(H,19,20,21)	UBENEGKGQZFLRG-UHFFFAOYSA-N	168226	US9669031, 55 8-chloro-3-methyl-6-(pyrimidin-4-ylamino)-3-(2,2,2-trifluoroethyl)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 55)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168226&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598672	373986987							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476129	CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C24H28ClN7O5/c1-23(2,3)37-22(36)31-8-6-24(7-9-31)30-20(34)18-14(25)10-15(21(35)32(18)24)28-16-11-17(27-12-26-16)29-19(33)13-4-5-13/h10-13H,4-9H2,1-3H3,(H,30,34)(H2,26,27,28,29,33)	APVPBFHXPCNODA-UHFFFAOYSA-N	168228	US9669031, 56 N-(6-((8-chloro-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidin]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide hydrochloride (Cpd. No. 56)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168228&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598848	373986988							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476130	CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C24H28ClN7O5/c1-23(2,3)37-22(36)31-8-6-24(7-9-31)30-20(34)18-14(25)10-15(21(35)32(18)24)28-16-11-17(27-12-26-16)29-19(33)13-4-5-13/h10-13H,4-9H2,1-3H3,(H,30,34)(H2,26,27,28,29,33)	APVPBFHXPCNODA-UHFFFAOYSA-N	168228	US9669031, 56 N-(6-((8-chloro-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidin]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide hydrochloride (Cpd. No. 56)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168228&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598848	373986988							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476131	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C18H13ClFN5O2/c1-18(10-3-2-4-11(20)7-10)24-16(26)15-12(19)8-13(17(27)25(15)18)23-14-5-6-21-9-22-14/h2-9H,1H3,(H,24,26)(H,21,22,23)	JSEUZOPUOHLOAX-UHFFFAOYSA-N	168229	US9669031, 57 8-chloro-3-(3-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 57)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168229&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598611	373986989							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476132	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C18H13ClFN5O2/c1-18(10-3-2-4-11(20)7-10)24-16(26)15-12(19)8-13(17(27)25(15)18)23-14-5-6-21-9-22-14/h2-9H,1H3,(H,24,26)(H,21,22,23)	JSEUZOPUOHLOAX-UHFFFAOYSA-N	168229	US9669031, 57 8-chloro-3-(3-fluorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 57)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168229&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598611	373986989							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476133	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C18H13Cl2N5O2/c1-18(10-3-2-4-11(19)7-10)24-16(26)15-12(20)8-13(17(27)25(15)18)23-14-5-6-21-9-22-14/h2-9H,1H3,(H,24,26)(H,21,22,23)	WPZRQSSHDQNJFD-UHFFFAOYSA-N	168230	US9669031, 58 8-chloro-3-(3-chlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 58)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168230&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598667	373986990							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476134	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C18H13Cl2N5O2/c1-18(10-3-2-4-11(19)7-10)24-16(26)15-12(20)8-13(17(27)25(15)18)23-14-5-6-21-9-22-14/h2-9H,1H3,(H,24,26)(H,21,22,23)	WPZRQSSHDQNJFD-UHFFFAOYSA-N	168230	US9669031, 58 8-chloro-3-(3-chlorophenyl)-3-methyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 58)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168230	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168230&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598667	373986990							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476135	CC1(NC(=O)c2ccc(Nc3cc(NC(C4CC4)C(F)(F)F)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C18H16F6N6O2/c1-16(18(22,23)24)29-14(31)10-5-4-9(15(32)30(10)16)27-11-6-12(26-7-25-11)28-13(8-2-3-8)17(19,20)21/h4-8,13H,2-3H2,1H3,(H,29,31)(H2,25,26,27,28)	LYDHAWXHLGNAQE-UHFFFAOYSA-N	168231	US9669031, 59 6-((6-((1-cyclopropyl-2,2,2-trifluoroethyl)amino)pyrimidin-4-yl)amino)-3-methyl-3-(trifluoromethyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 59)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168231&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598770	373986991							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476136	CC1(NC(=O)c2ccc(Nc3cc(NC(C4CC4)C(F)(F)F)ncn3)c(=O)n12)C(F)(F)F	InChI=1S/C18H16F6N6O2/c1-16(18(22,23)24)29-14(31)10-5-4-9(15(32)30(10)16)27-11-6-12(26-7-25-11)28-13(8-2-3-8)17(19,20)21/h4-8,13H,2-3H2,1H3,(H,29,31)(H2,25,26,27,28)	LYDHAWXHLGNAQE-UHFFFAOYSA-N	168231	US9669031, 59 6-((6-((1-cyclopropyl-2,2,2-trifluoroethyl)amino)pyrimidin-4-yl)amino)-3-methyl-3-(trifluoromethyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 59)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168231&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598770	373986991							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476137	CC(C)(C)OC(=O)N1CCCC2(C1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C24H28ClN7O5/c1-23(2,3)37-22(36)31-8-4-7-24(11-31)30-20(34)18-14(25)9-15(21(35)32(18)24)28-16-10-17(27-12-26-16)29-19(33)13-5-6-13/h9-10,12-13H,4-8,11H2,1-3H3,(H,30,34)(H2,26,27,28,29,33)	KCMPBXKWIPWQKV-UHFFFAOYSA-N	168232	US9669031, 60 N-(6-((8-chloro-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-piperidin]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide hydrochloride (Cpd. No. 60)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168232&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598801	373986992							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476138	CC(C)(C)OC(=O)N1CCCC2(C1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C24H28ClN7O5/c1-23(2,3)37-22(36)31-8-4-7-24(11-31)30-20(34)18-14(25)9-15(21(35)32(18)24)28-16-10-17(27-12-26-16)29-19(33)13-5-6-13/h9-10,12-13H,4-8,11H2,1-3H3,(H,30,34)(H2,26,27,28,29,33)	KCMPBXKWIPWQKV-UHFFFAOYSA-N	168232	US9669031, 60 N-(6-((8-chloro-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-piperidin]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide hydrochloride (Cpd. No. 60)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168232&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598801	373986992							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476139	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCOCC1	InChI=1S/C19H19ClN6O4/c20-11-7-12(23-13-8-14(22-9-21-13)24-16(27)10-1-2-10)18(29)26-15(11)17(28)25-19(26)3-5-30-6-4-19/h7-10H,1-6H2,(H,25,28)(H2,21,22,23,24,27)	FLLKKDXXLDBYPO-UHFFFAOYSA-N	168233	US9669031, 61 N-(6-((8-chloro-1,5-dioxo-1,2&#8242;,3&#8242;,5,5&#8242;,6&#8242;-hexahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-pyran]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 61)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168233&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598715	373986993							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476140	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCOCC1	InChI=1S/C19H19ClN6O4/c20-11-7-12(23-13-8-14(22-9-21-13)24-16(27)10-1-2-10)18(29)26-15(11)17(28)25-19(26)3-5-30-6-4-19/h7-10H,1-6H2,(H,25,28)(H2,21,22,23,24,27)	FLLKKDXXLDBYPO-UHFFFAOYSA-N	168233	US9669031, 61 N-(6-((8-chloro-1,5-dioxo-1,2&#8242;,3&#8242;,5,5&#8242;,6&#8242;-hexahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-pyran]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 61)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168233&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598715	373986993							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476141	FC1(F)CC2(C1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C18H15ClF2N6O3/c19-9-3-10(24-11-4-12(23-7-22-11)25-14(28)8-1-2-8)16(30)27-13(9)15(29)26-18(27)5-17(20,21)6-18/h3-4,7-8H,1-2,5-6H2,(H,26,29)(H2,22,23,24,25,28)	UHDGFZYDJUDIMJ-UHFFFAOYSA-N	168234	US9669031, 62 N-[6-[(8-chloro-1&#8242;,1&#8242;-difluoro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-cyclobutane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 62)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168234&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598637	373986994							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476142	FC1(F)CC2(C1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C18H15ClF2N6O3/c19-9-3-10(24-11-4-12(23-7-22-11)25-14(28)8-1-2-8)16(30)27-13(9)15(29)26-18(27)5-17(20,21)6-18/h3-4,7-8H,1-2,5-6H2,(H,26,29)(H2,22,23,24,25,28)	UHDGFZYDJUDIMJ-UHFFFAOYSA-N	168234	US9669031, 62 N-[6-[(8-chloro-1&#8242;,1&#8242;-difluoro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-cyclobutane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 62)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168234&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598637	373986994							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476143	CC1(C)CCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H18ClN5O2/c1-16(2)5-3-6-17(16)22-14(24)13-10(18)8-11(15(25)23(13)17)21-12-4-7-19-9-20-12/h4,7-9H,3,5-6H2,1-2H3,(H,22,24)(H,19,20,21)	YRWGYLSIDZELMS-UHFFFAOYSA-N	168235	US9669031, 63 8-chloro-2&#8242;,2&#8242;-dimethyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1, 5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione (Cpd. No. 63)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168235&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598896	373986995							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476144	CC1(C)CCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H18ClN5O2/c1-16(2)5-3-6-17(16)22-14(24)13-10(18)8-11(15(25)23(13)17)21-12-4-7-19-9-20-12/h4,7-9H,3,5-6H2,1-2H3,(H,22,24)(H,19,20,21)	YRWGYLSIDZELMS-UHFFFAOYSA-N	168235	US9669031, 63 8-chloro-2&#8242;,2&#8242;-dimethyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1, 5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione (Cpd. No. 63)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168235	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168235&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598896	373986995							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476145	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCOCC1	InChI=1S/C15H14ClN5O3/c16-9-7-10(19-11-1-4-17-8-18-11)14(23)21-12(9)13(22)20-15(21)2-5-24-6-3-15/h1,4,7-8H,2-3,5-6H2,(H,20,22)(H,17,18,19)	HHGUCXDDCLOWPZ-UHFFFAOYSA-N	168236	US9669031, 64 8-chloro-6-(pyrimidin-4-ylamino)-2&#8242;,3&#8242;,5&#8242;,6&#8242;-tetrahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-pyran]-1,5-dione (Cpd. No. 64)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168236&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599047	373986996							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476146	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCOCC1	InChI=1S/C15H14ClN5O3/c16-9-7-10(19-11-1-4-17-8-18-11)14(23)21-12(9)13(22)20-15(21)2-5-24-6-3-15/h1,4,7-8H,2-3,5-6H2,(H,20,22)(H,17,18,19)	HHGUCXDDCLOWPZ-UHFFFAOYSA-N	168236	US9669031, 64 8-chloro-6-(pyrimidin-4-ylamino)-2&#8242;,3&#8242;,5&#8242;,6&#8242;-tetrahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-pyran]-1,5-dione (Cpd. No. 64)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168236&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599047	373986996							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476147	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CSC1	InChI=1S/C17H15ClN6O3S/c18-9-3-10(16(27)24-13(9)15(26)23-17(24)5-28-6-17)21-11-4-12(20-7-19-11)22-14(25)8-1-2-8/h3-4,7-8H,1-2,5-6H2,(H,23,26)(H2,19,20,21,22,25)	DPVZLPBDWUAVQI-UHFFFAOYSA-N	168237	US9669031, 65 N-(6-((8-chloro-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-thietan]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 65)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168237&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598779	373986997							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476148	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CSC1	InChI=1S/C17H15ClN6O3S/c18-9-3-10(16(27)24-13(9)15(26)23-17(24)5-28-6-17)21-11-4-12(20-7-19-11)22-14(25)8-1-2-8/h3-4,7-8H,1-2,5-6H2,(H,23,26)(H2,19,20,21,22,25)	DPVZLPBDWUAVQI-UHFFFAOYSA-N	168237	US9669031, 65 N-(6-((8-chloro-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-thietan]-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 65)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168237&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598779	373986997							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476149	FC1CCCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C16H15ClFN5O2/c17-9-7-10(21-12-4-6-19-8-20-12)15(25)23-13(9)14(24)22-16(23)5-2-1-3-11(16)18/h4,6-8,11H,1-3,5H2,(H,22,24)(H,19,20,21)	AVWGOFIGHOXGPM-UHFFFAOYSA-N	168238	US9669031, 66 8-chloro-2&#8242;-fluoro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 66)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168238&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599097	373986998							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476150	FC1CCCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C16H15ClFN5O2/c17-9-7-10(21-12-4-6-19-8-20-12)15(25)23-13(9)14(24)22-16(23)5-2-1-3-11(16)18/h4,6-8,11H,1-3,5H2,(H,22,24)(H,19,20,21)	AVWGOFIGHOXGPM-UHFFFAOYSA-N	168238	US9669031, 66 8-chloro-2&#8242;-fluoro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 66)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168238&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599097	373986998							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476151	Cc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C14H15N5O2/c1-8-6-9(17-10-4-5-15-7-16-10)13(21)19-11(8)12(20)18-14(19,2)3/h4-7H,1-3H3,(H,18,20)(H,15,16,17)	JYJWZHLMBPNEJV-UHFFFAOYSA-N	168239	US9669031, 67 3,3,8-trimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 67)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168239&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598955	373986999							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476152	Cc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C14H15N5O2/c1-8-6-9(17-10-4-5-15-7-16-10)13(21)19-11(8)12(20)18-14(19,2)3/h4-7H,1-3H3,(H,18,20)(H,15,16,17)	JYJWZHLMBPNEJV-UHFFFAOYSA-N	168239	US9669031, 67 3,3,8-trimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 67)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168239&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598955	373986999							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476153	CC1(C)NC(=O)c2c(cc(Nc3ccncn3)c(=O)n12)C1CC1	InChI=1S/C16H17N5O2/c1-16(2)20-14(22)13-10(9-3-4-9)7-11(15(23)21(13)16)19-12-5-6-17-8-18-12/h5-9H,3-4H2,1-2H3,(H,20,22)(H,17,18,19)	SDLVOEKGXVIGLV-UHFFFAOYSA-N	168240	US9669031, 68 Synthesis 8-cyclopropyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 68)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168240&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598933	373987000							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476154	CC1(C)NC(=O)c2c(cc(Nc3ccncn3)c(=O)n12)C1CC1	InChI=1S/C16H17N5O2/c1-16(2)20-14(22)13-10(9-3-4-9)7-11(15(23)21(13)16)19-12-5-6-17-8-18-12/h5-9H,3-4H2,1-2H3,(H,20,22)(H,17,18,19)	SDLVOEKGXVIGLV-UHFFFAOYSA-N	168240	US9669031, 68 Synthesis 8-cyclopropyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 68)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168240&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598933	373987000							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476155	CC1(C)NC(=O)c2c(F)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12FN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	DWHJLJMQWMLRNN-UHFFFAOYSA-N	168241	US9669031, 69 8-fluoro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 69)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168241&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599128	373987001							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476156	CC1(C)NC(=O)c2c(F)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12FN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	DWHJLJMQWMLRNN-UHFFFAOYSA-N	168241	US9669031, 69 8-fluoro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 69)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168241&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599128	373987001							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476157	Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCOCC4)n3c2=O)ncn1	InChI=1S/C15H15ClN6O3/c16-8-5-9(20-11-6-10(17)18-7-19-11)14(24)22-12(8)13(23)21-15(22)1-3-25-4-2-15/h5-7H,1-4H2,(H,21,23)(H3,17,18,19,20)	BHMMTCYQVZTEFQ-UHFFFAOYSA-N	168242	US9669031, 70 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 70)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168242&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			122659714	373987002							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476158	Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCOCC4)n3c2=O)ncn1	InChI=1S/C15H15ClN6O3/c16-8-5-9(20-11-6-10(17)18-7-19-11)14(24)22-12(8)13(23)21-15(22)1-3-25-4-2-15/h5-7H,1-4H2,(H,21,23)(H3,17,18,19,20)	BHMMTCYQVZTEFQ-UHFFFAOYSA-N	168242	US9669031, 70 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 70)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168242&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			122659714	373987002							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476159	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476160	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476161	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1cccnc1	InChI=1S/C17H13ClN6O2/c1-17(10-3-2-5-19-8-10)23-15(25)14-11(18)7-12(16(26)24(14)17)22-13-4-6-20-9-21-13/h2-9H,1H3,(H,23,25)(H,20,21,22)	AJCYNHWVQLFTRE-UHFFFAOYSA-N	168244	US9669031, 72 8-chloro-3-methyl-3-(3-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 72)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168244&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598863	373987003							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476162	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1cccnc1	InChI=1S/C17H13ClN6O2/c1-17(10-3-2-5-19-8-10)23-15(25)14-11(18)7-12(16(26)24(14)17)22-13-4-6-20-9-21-13/h2-9H,1H3,(H,23,25)(H,20,21,22)	AJCYNHWVQLFTRE-UHFFFAOYSA-N	168244	US9669031, 72 8-chloro-3-methyl-3-(3-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 72)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168244&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598863	373987003							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476163	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1ccncc1	InChI=1S/C21H18ClN7O3/c1-21(12-4-6-23-7-5-12)28-19(31)17-13(22)8-14(20(32)29(17)21)26-15-9-16(25-10-24-15)27-18(30)11-2-3-11/h4-11H,2-3H2,1H3,(H,28,31)(H2,24,25,26,27,30)	OYYSVZVAIIIHQY-UHFFFAOYSA-N	168245	US9669031, 73 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(pyridin-4-yl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 73)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168245&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598876	373987004							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476164	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1ccncc1	InChI=1S/C21H18ClN7O3/c1-21(12-4-6-23-7-5-12)28-19(31)17-13(22)8-14(20(32)29(17)21)26-15-9-16(25-10-24-15)27-18(30)11-2-3-11/h4-11H,2-3H2,1H3,(H,28,31)(H2,24,25,26,27,30)	OYYSVZVAIIIHQY-UHFFFAOYSA-N	168245	US9669031, 73 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(pyridin-4-yl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 73)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168245&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598876	373987004							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476165	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1ccccn1	InChI=1S/C17H13ClN6O2/c1-17(12-4-2-3-6-20-12)23-15(25)14-10(18)8-11(16(26)24(14)17)22-13-5-7-19-9-21-13/h2-9H,1H3,(H,23,25)(H,19,21,22)	HZYNDUGPAYSCLX-UHFFFAOYSA-N	168246	US9669031, 74 8-chloro-3-methyl-3-(2-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 74)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168246&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598967	373987005							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476166	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1ccccn1	InChI=1S/C17H13ClN6O2/c1-17(12-4-2-3-6-20-12)23-15(25)14-10(18)8-11(16(26)24(14)17)22-13-5-7-19-9-21-13/h2-9H,1H3,(H,23,25)(H,19,21,22)	HZYNDUGPAYSCLX-UHFFFAOYSA-N	168246	US9669031, 74 8-chloro-3-methyl-3-(2-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 74)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168246&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598967	373987005							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476167	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1ccncc1	InChI=1S/C17H13ClN6O2/c1-17(10-2-5-19-6-3-10)23-15(25)14-11(18)8-12(16(26)24(14)17)22-13-4-7-20-9-21-13/h2-9H,1H3,(H,23,25)(H,20,21,22)	RJINHNWMTFJSBN-UHFFFAOYSA-N	168247	US9669031, 75 8-chloro-3-methyl-3-(4-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 75)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168247&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598766	373987006							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476168	CC1(NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12)c1ccncc1	InChI=1S/C17H13ClN6O2/c1-17(10-2-5-19-6-3-10)23-15(25)14-11(18)8-12(16(26)24(14)17)22-13-4-7-20-9-21-13/h2-9H,1H3,(H,23,25)(H,20,21,22)	RJINHNWMTFJSBN-UHFFFAOYSA-N	168247	US9669031, 75 8-chloro-3-methyl-3-(4-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 75)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168247&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598766	373987006							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476169	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1ccccn1	InChI=1S/C21H18ClN7O3/c1-21(14-4-2-3-7-23-14)28-19(31)17-12(22)8-13(20(32)29(17)21)26-15-9-16(25-10-24-15)27-18(30)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,28,31)(H2,24,25,26,27,30)	ZAKLQTSWAOFVCQ-UHFFFAOYSA-N	168248	US9669031, 76 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(pyridin-2-yl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 76)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168248&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598999	373987007							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476170	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1ccccn1	InChI=1S/C21H18ClN7O3/c1-21(14-4-2-3-7-23-14)28-19(31)17-12(22)8-13(20(32)29(17)21)26-15-9-16(25-10-24-15)27-18(30)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,28,31)(H2,24,25,26,27,30)	ZAKLQTSWAOFVCQ-UHFFFAOYSA-N	168248	US9669031, 76 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(pyridin-2-yl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 76)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168248&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598999	373987007							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476171	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccnc1	InChI=1S/C21H18ClN7O3/c1-21(12-3-2-6-23-9-12)28-19(31)17-13(22)7-14(20(32)29(17)21)26-15-8-16(25-10-24-15)27-18(30)11-4-5-11/h2-3,6-11H,4-5H2,1H3,(H,28,31)(H2,24,25,26,27,30)	MQVKGVWQIFOJPE-UHFFFAOYSA-N	168249	US9669031, 77 N-[6-[[8-chloro-3-methyl-1,5-dioxo-3-(3-pyridyl)-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 77)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168249&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599054	373987008							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476172	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccnc1	InChI=1S/C21H18ClN7O3/c1-21(12-3-2-6-23-9-12)28-19(31)17-13(22)7-14(20(32)29(17)21)26-15-8-16(25-10-24-15)27-18(30)11-4-5-11/h2-3,6-11H,4-5H2,1H3,(H,28,31)(H2,24,25,26,27,30)	MQVKGVWQIFOJPE-UHFFFAOYSA-N	168249	US9669031, 77 N-[6-[[8-chloro-3-methyl-1,5-dioxo-3-(3-pyridyl)-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 77)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168249&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599054	373987008							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476173	FC1CCCCC11NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C20H20ClFN6O3/c21-11-7-12(25-14-8-15(24-9-23-14)26-17(29)10-4-5-10)19(31)28-16(11)18(30)27-20(28)6-2-1-3-13(20)22/h7-10,13H,1-6H2,(H,27,30)(H2,23,24,25,26,29)	QOMAZSXQBKIGAM-UHFFFAOYSA-N	168250	US9669031, 78 N-(6-((8&#8242;-chloro-2-fluoro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 78)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168250&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598931	373987009							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476174	FC1CCCCC11NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C20H20ClFN6O3/c21-11-7-12(25-14-8-15(24-9-23-14)26-17(29)10-4-5-10)19(31)28-16(11)18(30)27-20(28)6-2-1-3-13(20)22/h7-10,13H,1-6H2,(H,27,30)(H2,23,24,25,26,29)	QOMAZSXQBKIGAM-UHFFFAOYSA-N	168250	US9669031, 78 N-(6-((8&#8242;-chloro-2-fluoro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 78)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168250&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598931	373987009							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476175	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476176	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476177	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(c1)C(F)(F)F	InChI=1S/C23H18ClF3N6O3/c1-22(12-3-2-4-13(7-12)23(25,26)27)32-20(35)18-14(24)8-15(21(36)33(18)22)30-16-9-17(29-10-28-16)31-19(34)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,32,35)(H2,28,29,30,31,34)	BPYYFLXJIDMFPO-UHFFFAOYSA-N	168252	US9669031, 80 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(3-(trifluoromethyl)phenyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 80)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168252&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599090	373987010							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476178	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(c1)C(F)(F)F	InChI=1S/C23H18ClF3N6O3/c1-22(12-3-2-4-13(7-12)23(25,26)27)32-20(35)18-14(24)8-15(21(36)33(18)22)30-16-9-17(29-10-28-16)31-19(34)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,32,35)(H2,28,29,30,31,34)	BPYYFLXJIDMFPO-UHFFFAOYSA-N	168252	US9669031, 80 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(3-(trifluoromethyl)phenyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 80)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168252&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599090	373987010							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476179	COc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C14H15N5O3/c1-14(2)18-12(20)11-9(22-3)6-8(13(21)19(11)14)17-10-4-5-15-7-16-10/h4-7H,1-3H3,(H,18,20)(H,15,16,17)	XORSAALTXBHPAL-UHFFFAOYSA-N	168253	US9669031, 81 8-methoxy-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 81)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168253&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598747	373987011							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476180	COc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C14H15N5O3/c1-14(2)18-12(20)11-9(22-3)6-8(13(21)19(11)14)17-10-4-5-15-7-16-10/h4-7H,1-3H3,(H,18,20)(H,15,16,17)	XORSAALTXBHPAL-UHFFFAOYSA-N	168253	US9669031, 81 8-methoxy-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 81)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168253&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598747	373987011							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476181	CSc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C14H15N5O2S/c1-14(2)18-12(20)11-9(22-3)6-8(13(21)19(11)14)17-10-4-5-15-7-16-10/h4-7H,1-3H3,(H,18,20)(H,15,16,17)	OLGSXYPPKJJNJR-UHFFFAOYSA-N	168254	US9669031, 82 3,3-dimethyl-8-methylsulfanyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 82)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168254&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598804	373987012							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476182	CSc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C14H15N5O2S/c1-14(2)18-12(20)11-9(22-3)6-8(13(21)19(11)14)17-10-4-5-15-7-16-10/h4-7H,1-3H3,(H,18,20)(H,15,16,17)	OLGSXYPPKJJNJR-UHFFFAOYSA-N	168254	US9669031, 82 3,3-dimethyl-8-methylsulfanyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 82)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168254&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598804	373987012							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476183	Cc1cccc(c1)C1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C23H21ClN6O3/c1-12-4-3-5-14(8-12)23(2)29-21(32)19-15(24)9-16(22(33)30(19)23)27-17-10-18(26-11-25-17)28-20(31)13-6-7-13/h3-5,8-11,13H,6-7H2,1-2H3,(H,29,32)(H2,25,26,27,28,31)	BTWBZSJFPTZYBY-UHFFFAOYSA-N	168255	US9669031, 83 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(m-tolyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 83)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168255&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598735	373987013							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476184	Cc1cccc(c1)C1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C23H21ClN6O3/c1-12-4-3-5-14(8-12)23(2)29-21(32)19-15(24)9-16(22(33)30(19)23)27-17-10-18(26-11-25-17)28-20(31)13-6-7-13/h3-5,8-11,13H,6-7H2,1-2H3,(H,29,32)(H2,25,26,27,28,31)	BTWBZSJFPTZYBY-UHFFFAOYSA-N	168255	US9669031, 83 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-(m-tolyl)-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 83)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168255&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598735	373987013							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476185	CC(C)(C)C1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C20H23ClN6O3/c1-19(2,3)20(4)26-17(29)15-11(21)7-12(18(30)27(15)20)24-13-8-14(23-9-22-13)25-16(28)10-5-6-10/h7-10H,5-6H2,1-4H3,(H,26,29)(H2,22,23,24,25,28)	JKUGXMWSWANUFK-UHFFFAOYSA-N	168256	US9669031, 84 N-[6-[(3-tert-butyl-8-chloro-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 84)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168256&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598929	373987014							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476186	CC(C)(C)C1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C20H23ClN6O3/c1-19(2,3)20(4)26-17(29)15-11(21)7-12(18(30)27(15)20)24-13-8-14(23-9-22-13)25-16(28)10-5-6-10/h7-10H,5-6H2,1-4H3,(H,26,29)(H2,22,23,24,25,28)	JKUGXMWSWANUFK-UHFFFAOYSA-N	168256	US9669031, 84 N-[6-[(3-tert-butyl-8-chloro-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 84)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168256&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598929	373987014							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476187	FC(F)(F)C1NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C16H12ClF3N6O3/c17-7-3-8(14(29)26-11(7)13(28)25-15(26)16(18,19)20)23-9-4-10(22-5-21-9)24-12(27)6-1-2-6/h3-6,15H,1-2H2,(H,25,28)(H2,21,22,23,24,27)	JWPVAEWSXASABU-UHFFFAOYSA-N	168257	US9669031, 85 N-[6-[[8-chloro-1,5-dioxo-3-(trifluoromethyl)-2,3-dihydroimidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 85)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168257&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599011	373987015							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476188	FC(F)(F)C1NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C16H12ClF3N6O3/c17-7-3-8(14(29)26-11(7)13(28)25-15(26)16(18,19)20)23-9-4-10(22-5-21-9)24-12(27)6-1-2-6/h3-6,15H,1-2H2,(H,25,28)(H2,21,22,23,24,27)	JWPVAEWSXASABU-UHFFFAOYSA-N	168257	US9669031, 85 N-[6-[[8-chloro-1,5-dioxo-3-(trifluoromethyl)-2,3-dihydroimidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 85)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168257&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599011	373987015							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476189	CC(C)(C)OC(=O)N1CC2(C1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C22H24ClN7O5/c1-21(2,3)35-20(34)29-8-22(9-29)28-18(32)16-12(23)6-13(19(33)30(16)22)26-14-7-15(25-10-24-14)27-17(31)11-4-5-11/h6-7,10-11H,4-5,8-9H2,1-3H3,(H,28,32)(H2,24,25,26,27,31)	JFNOOFBICQMJGT-UHFFFAOYSA-N	168258	US9669031, 86 N-[6-[(8-chloro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-azetidine]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide hydrochloride (Cpd. No. 86)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168258&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599114	373987016							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476190	CC(C)(C)OC(=O)N1CC2(C1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C22H24ClN7O5/c1-21(2,3)35-20(34)29-8-22(9-29)28-18(32)16-12(23)6-13(19(33)30(16)22)26-14-7-15(25-10-24-14)27-17(31)11-4-5-11/h6-7,10-11H,4-5,8-9H2,1-3H3,(H,28,32)(H2,24,25,26,27,31)	JFNOOFBICQMJGT-UHFFFAOYSA-N	168258	US9669031, 86 N-[6-[(8-chloro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-azetidine]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide hydrochloride (Cpd. No. 86)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168258&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599114	373987016							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476191	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C22H18ClFN6O3/c1-22(12-3-2-4-13(24)7-12)29-20(32)18-14(23)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	BTPOGDUCUHHPDU-UHFFFAOYSA-N	168223	US9669031, 52 N-[6-[[8-chloro-3-(3-fluorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 52)::US9669031, 87 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-fluorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 87)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168223&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598561	373986984							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476192	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(F)c1	InChI=1S/C22H18ClFN6O3/c1-22(12-3-2-4-13(24)7-12)29-20(32)18-14(23)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	BTPOGDUCUHHPDU-UHFFFAOYSA-N	168223	US9669031, 52 N-[6-[[8-chloro-3-(3-fluorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 52)::US9669031, 87 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-fluorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 87)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168223&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598561	373986984							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476193	CC1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C17H17ClN6O3/c1-17(2)23-15(26)13-9(18)5-10(16(27)24(13)17)21-11-6-12(20-7-19-11)22-14(25)8-3-4-8/h5-8H,3-4H2,1-2H3,(H,23,26)(H2,19,20,21,22,25)	MSMODVCLZGRBDS-UHFFFAOYSA-N	168212	US9669031, 43 N-[6-[(8-chloro-3,3-dimethyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 43)::US9669031, 88 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3,3-dimethyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 88)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168212&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598805	373986975							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476194	CC1(C)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C17H17ClN6O3/c1-17(2)23-15(26)13-9(18)5-10(16(27)24(13)17)21-11-6-12(20-7-19-11)22-14(25)8-3-4-8/h5-8H,3-4H2,1-2H3,(H,23,26)(H2,19,20,21,22,25)	MSMODVCLZGRBDS-UHFFFAOYSA-N	168212	US9669031, 43 N-[6-[(8-chloro-3,3-dimethyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 43)::US9669031, 88 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3,3-dimethyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 88)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168212	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168212&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598805	373986975							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476195	CNc1cc(Nc2cc(Cl)c3C(=O)NC(C)(c4cccc(Cl)c4)n3c2=O)ncn1	InChI=1S/C19H16Cl2N6O2/c1-19(10-4-3-5-11(20)6-10)26-17(28)16-12(21)7-13(18(29)27(16)19)25-15-8-14(22-2)23-9-24-15/h3-9H,1-2H3,(H,26,28)(H2,22,23,24,25)	AEOGHGSLKIMNLB-UHFFFAOYSA-N	168261	US9669031, 89 8-chloro-3-(3-chlorophenyl)-3-methyl-6-[[6-(methylamino)pyrimidin-4-yl]amino]-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 89)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168261&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598920	373987017							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476196	CNc1cc(Nc2cc(Cl)c3C(=O)NC(C)(c4cccc(Cl)c4)n3c2=O)ncn1	InChI=1S/C19H16Cl2N6O2/c1-19(10-4-3-5-11(20)6-10)26-17(28)16-12(21)7-13(18(29)27(16)19)25-15-8-14(22-2)23-9-24-15/h3-9H,1-2H3,(H,26,28)(H2,22,23,24,25)	AEOGHGSLKIMNLB-UHFFFAOYSA-N	168261	US9669031, 89 8-chloro-3-(3-chlorophenyl)-3-methyl-6-[[6-(methylamino)pyrimidin-4-yl]amino]-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 89)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168261&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598920	373987017							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476197	Cc1cccc(n1)C1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C18H15ClN6O2/c1-10-4-3-5-13(22-10)18(2)24-16(26)15-11(19)8-12(17(27)25(15)18)23-14-6-7-20-9-21-14/h3-9H,1-2H3,(H,24,26)(H,20,21,23)	GKVROHXTZSCWTI-UHFFFAOYSA-N	168262	US9669031, 90 8-chloro-3-methyl-3-(6-methyl-2-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 90)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168262&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598668	373987018							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476198	Cc1cccc(n1)C1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C18H15ClN6O2/c1-10-4-3-5-13(22-10)18(2)24-16(26)15-11(19)8-12(17(27)25(15)18)23-14-6-7-20-9-21-14/h3-9H,1-2H3,(H,24,26)(H,20,21,23)	GKVROHXTZSCWTI-UHFFFAOYSA-N	168262	US9669031, 90 8-chloro-3-methyl-3-(6-methyl-2-pyridyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 90)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168262&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598668	373987018							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476199	Fc1cccc(c1)C1NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C21H16ClFN6O3/c22-13-7-14(26-15-8-16(25-9-24-15)27-19(30)10-4-5-10)21(32)29-17(13)20(31)28-18(29)11-2-1-3-12(23)6-11/h1-3,6-10,18H,4-5H2,(H,28,31)(H2,24,25,26,27,30)	RIZCTXIJHJFDLN-UHFFFAOYSA-N	168263	US9669031, 91 N-[6-[[8-chloro-3-(3-fluorophenyl)-1,5-dioxo-2,3-dihydroimidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 91)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168263&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599064	373987019							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476200	Fc1cccc(c1)C1NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12	InChI=1S/C21H16ClFN6O3/c22-13-7-14(26-15-8-16(25-9-24-15)27-19(30)10-4-5-10)21(32)29-17(13)20(31)28-18(29)11-2-1-3-12(23)6-11/h1-3,6-10,18H,4-5H2,(H,28,31)(H2,24,25,26,27,30)	RIZCTXIJHJFDLN-UHFFFAOYSA-N	168263	US9669031, 91 N-[6-[[8-chloro-3-(3-fluorophenyl)-1,5-dioxo-2,3-dihydroimidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 91)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168263&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599064	373987019							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476201	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC2(C)c1cccc(Cl)c1	InChI=1S/C24H25ClN6O4/c1-13-9-16(28-17-11-18(27-12-26-17)29-22(34)35-23(2,3)4)21(33)31-19(13)20(32)30-24(31,5)14-7-6-8-15(25)10-14/h6-12H,1-5H3,(H,30,32)(H2,26,27,28,29,34)	UXXALADLUMSSBG-UHFFFAOYSA-N	168264	US9669031, 92 6-[(6-aminopyrimidin-4-yl)amino]-3-(3-chlorophenyl)-3,8-dimethyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 92)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168264&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599113	373987020							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476202	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC2(C)c1cccc(Cl)c1	InChI=1S/C24H25ClN6O4/c1-13-9-16(28-17-11-18(27-12-26-17)29-22(34)35-23(2,3)4)21(33)31-19(13)20(32)30-24(31,5)14-7-6-8-15(25)10-14/h6-12H,1-5H3,(H,30,32)(H2,26,27,28,29,34)	UXXALADLUMSSBG-UHFFFAOYSA-N	168264	US9669031, 92 6-[(6-aminopyrimidin-4-yl)amino]-3-(3-chlorophenyl)-3,8-dimethyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 92)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168264&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599113	373987020							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476203	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C22H18Cl2N6O3/c1-22(12-3-2-4-13(23)7-12)29-20(32)18-14(24)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	RZKFMYXHNVBJJV-UHFFFAOYSA-N	168222	US9669031, 51 N-[6-[[8-chloro-3-(3-chlorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 51)::US9669031, 93 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-chlorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 93)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168222&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599023	373986983							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476204	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1cccc(Cl)c1	InChI=1S/C22H18Cl2N6O3/c1-22(12-3-2-4-13(23)7-12)29-20(32)18-14(24)8-15(21(33)30(18)22)27-16-9-17(26-10-25-16)28-19(31)11-5-6-11/h2-4,7-11H,5-6H2,1H3,(H,29,32)(H2,25,26,27,28,31)	RZKFMYXHNVBJJV-UHFFFAOYSA-N	168222	US9669031, 51 N-[6-[[8-chloro-3-(3-chlorophenyl)-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl]amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 51)::US9669031, 93 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-chlorophenyl)-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 93)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168222&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599023	373986983							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476205	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCCC4)n3c2=O)ncn1	InChI=1S/C20H23ClN6O4/c1-19(2,3)31-18(30)25-14-9-13(22-10-23-14)24-12-8-11(21)15-16(28)26-20(6-4-5-7-20)27(15)17(12)29/h8-10H,4-7H2,1-3H3,(H,26,28)(H2,22,23,24,25,30)	YXDMHUJLKKFGQT-UHFFFAOYSA-N	168266	US9669031, 94 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione (Cpd. No. 94)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168266&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598861	373987021							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476206	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCCC4)n3c2=O)ncn1	InChI=1S/C20H23ClN6O4/c1-19(2,3)31-18(30)25-14-9-13(22-10-23-14)24-12-8-11(21)15-16(28)26-20(6-4-5-7-20)27(15)17(12)29/h8-10H,4-7H2,1-3H3,(H,26,28)(H2,22,23,24,25,30)	YXDMHUJLKKFGQT-UHFFFAOYSA-N	168266	US9669031, 94 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione (Cpd. No. 94)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168266&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598861	373987021							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476207	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CS(=O)C1	InChI=1S/C17H15ClN6O4S/c18-9-3-10(16(27)24-13(9)15(26)23-17(24)5-29(28)6-17)21-11-4-12(20-7-19-11)22-14(25)8-1-2-8/h3-4,7-8H,1-2,5-6H2,(H,23,26)(H2,19,20,21,22,25)	MRKSLEAHVVXUHM-UHFFFAOYSA-N	168267	US9669031, 95 N-[6-[(8-chloro-1,1&#8242;,5-trioxo-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-thietane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 95)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168267&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598910	373987022							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476208	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CS(=O)C1	InChI=1S/C17H15ClN6O4S/c18-9-3-10(16(27)24-13(9)15(26)23-17(24)5-29(28)6-17)21-11-4-12(20-7-19-11)22-14(25)8-1-2-8/h3-4,7-8H,1-2,5-6H2,(H,23,26)(H2,19,20,21,22,25)	MRKSLEAHVVXUHM-UHFFFAOYSA-N	168267	US9669031, 95 N-[6-[(8-chloro-1,1&#8242;,5-trioxo-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-thietane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 95)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168267&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598910	373987022							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476209	CC1(C)CCCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C18H20ClN5O2/c1-17(2)6-3-4-7-18(17)23-15(25)14-11(19)9-12(16(26)24(14)18)22-13-5-8-20-10-21-13/h5,8-10H,3-4,6-7H2,1-2H3,(H,23,25)(H,20,21,22)	HRQIBOBTQVIXCH-UHFFFAOYSA-N	168268	US9669031, 96 8-chloro-1&#8242;,1&#8242;-dimethyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,2&#8242;-cyclohexane]-1,5-dione (Cpd. No. 96)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168268&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598916	373987023							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476210	CC1(C)CCCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C18H20ClN5O2/c1-17(2)6-3-4-7-18(17)23-15(25)14-11(19)9-12(16(26)24(14)18)22-13-5-8-20-10-21-13/h5,8-10H,3-4,6-7H2,1-2H3,(H,23,25)(H,20,21,22)	HRQIBOBTQVIXCH-UHFFFAOYSA-N	168268	US9669031, 96 8-chloro-1&#8242;,1&#8242;-dimethyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,2&#8242;-cyclohexane]-1,5-dione (Cpd. No. 96)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168268&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598916	373987023							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476211	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1ccccc1	InChI=1S/C22H19ClN6O3/c1-22(13-5-3-2-4-6-13)28-20(31)18-14(23)9-15(21(32)29(18)22)26-16-10-17(25-11-24-16)27-19(30)12-7-8-12/h2-6,9-12H,7-8H2,1H3,(H,28,31)(H2,24,25,26,27,30)	QAIVUOYXMDYZIM-UHFFFAOYSA-N	168269	US9669031, 97 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-phenyl-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 97)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168269&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598686	373987024							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476212	CC1(NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)c1ccccc1	InChI=1S/C22H19ClN6O3/c1-22(13-5-3-2-4-6-13)28-20(31)18-14(23)9-15(21(32)29(18)22)26-16-10-17(25-11-24-16)27-19(30)12-7-8-12/h2-6,9-12H,7-8H2,1H3,(H,28,31)(H2,24,25,26,27,30)	QAIVUOYXMDYZIM-UHFFFAOYSA-N	168269	US9669031, 97 N-(6-((8-chloro-3-methyl-1,5-dioxo-3-phenyl-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 97)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168269&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598686	373987024							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476213	Cc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCC1	InChI=1S/C20H22N6O3/c1-11-8-13(19(29)26-16(11)18(28)25-20(26)6-2-3-7-20)23-14-9-15(22-10-21-14)24-17(27)12-4-5-12/h8-10,12H,2-7H2,1H3,(H,25,28)(H2,21,22,23,24,27)	PZVYZODLZVQLLT-UHFFFAOYSA-N	168270	US9669031, 98 6-[(6-aminopyrimidin-4-yl)amino]-8-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione hydrochloride (Cpd. No. 98)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168270&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598776	373987025							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476214	Cc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCC1	InChI=1S/C20H22N6O3/c1-11-8-13(19(29)26-16(11)18(28)25-20(26)6-2-3-7-20)23-14-9-15(22-10-21-14)24-17(27)12-4-5-12/h8-10,12H,2-7H2,1H3,(H,25,28)(H2,21,22,23,24,27)	PZVYZODLZVQLLT-UHFFFAOYSA-N	168270	US9669031, 98 6-[(6-aminopyrimidin-4-yl)amino]-8-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclopentane]-1,5-dione hydrochloride (Cpd. No. 98)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168270&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598776	373987025							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476215	FC1(F)CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C20H19ClF2N6O3/c21-11-7-12(26-13-8-14(25-9-24-13)27-16(30)10-1-2-10)18(32)29-15(11)17(31)28-20(29)5-3-19(22,23)4-6-20/h7-10H,1-6H2,(H,28,31)(H2,24,25,26,27,30)	WUCBMAZIUGCYRG-UHFFFAOYSA-N	168221	US9669031, 50 N-[6-[(8-chloro-4&#8242;,4&#8242;-difluoro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 50)::US9669031, 99 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-4&#8242;,4&#8242;-difluoro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 99)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168221&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598601	373986982							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476216	FC1(F)CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21	InChI=1S/C20H19ClF2N6O3/c21-11-7-12(26-13-8-14(25-9-24-13)27-16(30)10-1-2-10)18(32)29-15(11)17(31)28-20(29)5-3-19(22,23)4-6-20/h7-10H,1-6H2,(H,28,31)(H2,24,25,26,27,30)	WUCBMAZIUGCYRG-UHFFFAOYSA-N	168221	US9669031, 50 N-[6-[(8-chloro-4&#8242;,4&#8242;-difluoro-1,5-dioxo-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 50)::US9669031, 99 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-4&#8242;,4&#8242;-difluoro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 99)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168221&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598601	373986982							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476217	CC1(C)NC(=O)c2c(Cl)cc(Nc3ncnc4cc(ncc34)C3CC3)c(=O)n12	InChI=1S/C19H17ClN6O2/c1-19(2)25-17(27)15-11(20)5-14(18(28)26(15)19)24-16-10-7-21-12(9-3-4-9)6-13(10)22-8-23-16/h5-9H,3-4H2,1-2H3,(H,25,27)(H,22,23,24)	SBCXCVDWUGIHQA-UHFFFAOYSA-N	168272	US9669031, 100 8-chloro-6-((7-cyclopropylpyrido[4,3-d]pyrimidin-4-yl)amino)-3,3-dimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 100)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168272&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598647	373987026							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476218	CC1(C)NC(=O)c2c(Cl)cc(Nc3ncnc4cc(ncc34)C3CC3)c(=O)n12	InChI=1S/C19H17ClN6O2/c1-19(2)25-17(27)15-11(20)5-14(18(28)26(15)19)24-16-10-7-21-12(9-3-4-9)6-13(10)22-8-23-16/h5-9H,3-4H2,1-2H3,(H,25,27)(H,22,23,24)	SBCXCVDWUGIHQA-UHFFFAOYSA-N	168272	US9669031, 100 8-chloro-6-((7-cyclopropylpyrido[4,3-d]pyrimidin-4-yl)amino)-3,3-dimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 100)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168272&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598647	373987026							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476219	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC2(C)c1cccc(F)c1	InChI=1S/C24H25FN6O4/c1-13-9-16(28-17-11-18(27-12-26-17)29-22(34)35-23(2,3)4)21(33)31-19(13)20(32)30-24(31,5)14-7-6-8-15(25)10-14/h6-12H,1-5H3,(H,30,32)(H2,26,27,28,29,34)	TUHMBVLQAVFGSO-UHFFFAOYSA-N	168273	US9669031, 101 6-((6-aminopyrimidin-4-yl)amino)-3-(3-fluorophenyl)-3,8-dimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 101)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168273&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118604425	373987027							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476220	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC2(C)c1cccc(F)c1	InChI=1S/C24H25FN6O4/c1-13-9-16(28-17-11-18(27-12-26-17)29-22(34)35-23(2,3)4)21(33)31-19(13)20(32)30-24(31,5)14-7-6-8-15(25)10-14/h6-12H,1-5H3,(H,30,32)(H2,26,27,28,29,34)	TUHMBVLQAVFGSO-UHFFFAOYSA-N	168273	US9669031, 101 6-((6-aminopyrimidin-4-yl)amino)-3-(3-fluorophenyl)-3,8-dimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 101)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168273	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168273&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604425	373987027							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476221	Cc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C18H20N6O3/c1-9-6-11(17(27)24-14(9)16(26)23-18(24,2)3)21-12-7-13(20-8-19-12)22-15(25)10-4-5-10/h6-8,10H,4-5H2,1-3H3,(H,23,26)(H2,19,20,21,22,25)	DLLXVIOXDUQAPH-UHFFFAOYSA-N	168274	US9669031, 102 6-((6-aminopyrimidin-4-yl)amino)-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione hydrochloride (Cpd. No. 102)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168274&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599008	373987028							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476222	Cc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC2(C)C	InChI=1S/C18H20N6O3/c1-9-6-11(17(27)24-14(9)16(26)23-18(24,2)3)21-12-7-13(20-8-19-12)22-15(25)10-4-5-10/h6-8,10H,4-5H2,1-3H3,(H,23,26)(H2,19,20,21,22,25)	DLLXVIOXDUQAPH-UHFFFAOYSA-N	168274	US9669031, 102 6-((6-aminopyrimidin-4-yl)amino)-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione hydrochloride (Cpd. No. 102)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168274	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168274&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599008	373987028							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476223	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1	InChI=1S/C22H26F2N6O4/c1-12-9-13(27-14-10-15(26-11-25-14)28-19(33)34-20(2,3)4)18(32)30-16(12)17(31)29-22(30)7-5-21(23,24)6-8-22/h9-11H,5-8H2,1-4H3,(H,29,31)(H2,25,26,27,28,33)	KFZYKOXFXNOCQR-UHFFFAOYSA-N	168275	US9669031, 103 6-[(6-aminopyrimidin-4-yl)amino]-4&#8242;,4&#8242;-difluoro-8-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 103)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168275&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599038	373987029							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476224	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1	InChI=1S/C22H26F2N6O4/c1-12-9-13(27-14-10-15(26-11-25-14)28-19(33)34-20(2,3)4)18(32)30-16(12)17(31)29-22(30)7-5-21(23,24)6-8-22/h9-11H,5-8H2,1-4H3,(H,29,31)(H2,25,26,27,28,33)	KFZYKOXFXNOCQR-UHFFFAOYSA-N	168275	US9669031, 103 6-[(6-aminopyrimidin-4-yl)amino]-4&#8242;,4&#8242;-difluoro-8-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 103)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168275	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168275&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599038	373987029							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476225	CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C20H23ClN6O4/c1-19(2,3)31-18(30)26-8-5-20(6-9-26)25-16(28)15-12(21)10-13(17(29)27(15)20)24-14-4-7-22-11-23-14/h4,7,10-11H,5-6,8-9H2,1-3H3,(H,25,28)(H,22,23,24)	HMABOMFZFKMLGM-UHFFFAOYSA-N	168276	US9669031, 104 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 104)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168276&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598919	373987030							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476226	CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C20H23ClN6O4/c1-19(2,3)31-18(30)26-8-5-20(6-9-26)25-16(28)15-12(21)10-13(17(29)27(15)20)24-14-4-7-22-11-23-14/h4,7,10-11H,5-6,8-9H2,1-3H3,(H,25,28)(H,22,23,24)	HMABOMFZFKMLGM-UHFFFAOYSA-N	168276	US9669031, 104 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 104)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168276	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168276&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598919	373987030							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476227	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC(C)(n3c2=O)C(C)(C)C)ncn1	InChI=1S/C21H27ClN6O4/c1-19(2,3)21(7)27-16(29)15-11(22)8-12(17(30)28(15)21)25-13-9-14(24-10-23-13)26-18(31)32-20(4,5)6/h8-10H,1-7H3,(H,27,29)(H2,23,24,25,26,31)	ZRBMJKFMPALIJN-UHFFFAOYSA-N	168277	US9669031, 105 6-[(6-aminopyrimidin-4-yl)amino]-3-tert-butyl-8-chloro-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione hydrochloride (Cpd. No. 105)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168277&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598781	373987031							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476228	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC(C)(n3c2=O)C(C)(C)C)ncn1	InChI=1S/C21H27ClN6O4/c1-19(2,3)21(7)27-16(29)15-11(22)8-12(17(30)28(15)21)25-13-9-14(24-10-23-13)26-18(31)32-20(4,5)6/h8-10H,1-7H3,(H,27,29)(H2,23,24,25,26,31)	ZRBMJKFMPALIJN-UHFFFAOYSA-N	168277	US9669031, 105 6-[(6-aminopyrimidin-4-yl)amino]-3-tert-butyl-8-chloro-3-methyl-2H-imidazo[1,5-a]pyridine-1,5-dione hydrochloride (Cpd. No. 105)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168277	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168277&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598781	373987031							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476229	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC21CCN(CC1)C(=O)OC(C)(C)C	InChI=1S/C26H35N7O6/c1-15-12-16(29-17-13-18(28-14-27-17)30-22(36)38-24(2,3)4)21(35)33-19(15)20(34)31-26(33)8-10-32(11-9-26)23(37)39-25(5,6)7/h12-14H,8-11H2,1-7H3,(H,31,34)(H2,27,28,29,30,36)	RKFFONLBELGAAG-UHFFFAOYSA-N	168278	US9669031, 106 6-((6-aminopyrimidin-4-yl)amino)-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione dihydrochloride (Cpd. No. 106)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168278&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118604427	373987032							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476230	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC21CCN(CC1)C(=O)OC(C)(C)C	InChI=1S/C26H35N7O6/c1-15-12-16(29-17-13-18(28-14-27-17)30-22(36)38-24(2,3)4)21(35)33-19(15)20(34)31-26(33)8-10-32(11-9-26)23(37)39-25(5,6)7/h12-14H,8-11H2,1-7H3,(H,31,34)(H2,27,28,29,30,36)	RKFFONLBELGAAG-UHFFFAOYSA-N	168278	US9669031, 106 6-((6-aminopyrimidin-4-yl)amino)-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione dihydrochloride (Cpd. No. 106)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168278	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168278&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604427	373987032							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476231	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C22H28N6O4/c1-13-10-14(19(30)28-17(13)18(29)27-22(28)8-6-5-7-9-22)25-15-11-16(24-12-23-15)26-20(31)32-21(2,3)4/h10-12H,5-9H2,1-4H3,(H,27,29)(H2,23,24,25,26,31)	RXXKEAPBZRGJKS-UHFFFAOYSA-N	168279	US9669031, 107 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 107)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168279&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118604429	373987033							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476232	Cc1cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C22H28N6O4/c1-13-10-14(19(30)28-17(13)18(29)27-22(28)8-6-5-7-9-22)25-15-11-16(24-12-23-15)26-20(31)32-21(2,3)4/h10-12H,5-9H2,1-4H3,(H,27,29)(H2,23,24,25,26,31)	RXXKEAPBZRGJKS-UHFFFAOYSA-N	168279	US9669031, 107 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 107)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168279	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168279&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604429	373987033							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476233	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCN(CC4)C(=O)OC(C)(C)C)n3c2=O)ncn1	InChI=1S/C25H32ClN7O6/c1-23(2,3)38-21(36)30-17-12-16(27-13-28-17)29-15-11-14(26)18-19(34)31-25(33(18)20(15)35)7-9-32(10-8-25)22(37)39-24(4,5)6/h11-13H,7-10H2,1-6H3,(H,31,34)(H2,27,28,29,30,36)	FQBJAJAOINCQKU-UHFFFAOYSA-N	168280	US9669031, 108 6-((6-aminopyrimidin-4-yl)amino)-8-chloro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione dihydrochloride (Cpd. No. 108)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168280&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118604428	373987034							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476234	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCN(CC4)C(=O)OC(C)(C)C)n3c2=O)ncn1	InChI=1S/C25H32ClN7O6/c1-23(2,3)38-21(36)30-17-12-16(27-13-28-17)29-15-11-14(26)18-19(34)31-25(33(18)20(15)35)7-9-32(10-8-25)22(37)39-24(4,5)6/h11-13H,7-10H2,1-6H3,(H,31,34)(H2,27,28,29,30,36)	FQBJAJAOINCQKU-UHFFFAOYSA-N	168280	US9669031, 108 6-((6-aminopyrimidin-4-yl)amino)-8-chloro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione dihydrochloride (Cpd. No. 108)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168280	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168280&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604428	373987034							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476235	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C16H16ClN5O2/c17-10-8-11(20-12-4-7-18-9-19-12)15(24)22-13(10)14(23)21-16(22)5-2-1-3-6-16/h4,7-9H,1-3,5-6H2,(H,21,23)(H,18,19,20)	OEVBYHNIUPOXDX-UHFFFAOYSA-N	168281	US9669031, 109 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 109)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168281&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598782	373987035							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476236	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C16H16ClN5O2/c17-10-8-11(20-12-4-7-18-9-19-12)15(24)22-13(10)14(23)21-16(22)5-2-1-3-6-16/h4,7-9H,1-3,5-6H2,(H,21,23)(H,18,19,20)	OEVBYHNIUPOXDX-UHFFFAOYSA-N	168281	US9669031, 109 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 109)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168281	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168281&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598782	373987035							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476237	FC1(F)CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C16H14ClF2N5O2/c17-9-7-10(22-11-1-6-20-8-21-11)14(26)24-12(9)13(25)23-16(24)4-2-15(18,19)3-5-16/h1,6-8H,2-5H2,(H,23,25)(H,20,21,22)	GGICRDSGZDXVSN-UHFFFAOYSA-N	168282	US9669031, 110 8-chloro-4&#8242;,4&#8242;-difluoro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 110)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168282&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599032	373987036							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476238	FC1(F)CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C16H14ClF2N5O2/c17-9-7-10(22-11-1-6-20-8-21-11)14(26)24-12(9)13(25)23-16(24)4-2-15(18,19)3-5-16/h1,6-8H,2-5H2,(H,23,25)(H,20,21,22)	GGICRDSGZDXVSN-UHFFFAOYSA-N	168282	US9669031, 110 8-chloro-4&#8242;,4&#8242;-difluoro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 110)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168282	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168282&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599032	373987036							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476239	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCc5ccc(Cl)cc45)n3c2=O)ncn1	InChI=1S/C24H22Cl2N6O4/c1-23(2,3)36-22(35)30-18-10-17(27-11-28-18)29-16-9-15(26)19-20(33)31-24(32(19)21(16)34)7-6-12-4-5-13(25)8-14(12)24/h4-5,8-11H,6-7H2,1-3H3,(H,31,33)(H2,27,28,29,30,35)	OEVSOLVCUNKPNP-UHFFFAOYSA-N	168283	US9669031, 111 6-[(6-aminopyrimidin-4-yl)amino]-6&#8242;,8-dichloro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-indane]-1,5-dione hydrochloride (Cpd. No. 111)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168283&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598859	373987037							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476240	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCc5ccc(Cl)cc45)n3c2=O)ncn1	InChI=1S/C24H22Cl2N6O4/c1-23(2,3)36-22(35)30-18-10-17(27-11-28-18)29-16-9-15(26)19-20(33)31-24(32(19)21(16)34)7-6-12-4-5-13(25)8-14(12)24/h4-5,8-11H,6-7H2,1-3H3,(H,31,33)(H2,27,28,29,30,35)	OEVSOLVCUNKPNP-UHFFFAOYSA-N	168283	US9669031, 111 6-[(6-aminopyrimidin-4-yl)amino]-6&#8242;,8-dichloro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-indane]-1,5-dione hydrochloride (Cpd. No. 111)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168283	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168283&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598859	373987037							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476241	Fc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C16H15ClFN5O2/c17-9-6-11(21-13-10(18)7-19-8-20-13)15(25)23-12(9)14(24)22-16(23)4-2-1-3-5-16/h6-8H,1-5H2,(H,22,24)(H,19,20,21)	ZDRUJHPKBGEVQG-UHFFFAOYSA-N	168284	US9669031, 112 8-chloro-6-[(5-fluoropyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 112)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168284&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598711	373987038							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476242	Fc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C16H15ClFN5O2/c17-9-6-11(21-13-10(18)7-19-8-20-13)15(25)23-12(9)14(24)22-16(23)4-2-1-3-5-16/h6-8H,1-5H2,(H,22,24)(H,19,20,21)	ZDRUJHPKBGEVQG-UHFFFAOYSA-N	168284	US9669031, 112 8-chloro-6-[(5-fluoropyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 112)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168284	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168284&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598711	373987038							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476243	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21Cc2ccccc2C1=O	InChI=1S/C19H12ClN5O3/c20-12-7-13(23-14-5-6-21-9-22-14)18(28)25-15(12)17(27)24-19(25)8-10-3-1-2-4-11(10)16(19)26/h1-7,9H,8H2,(H,24,27)(H,21,22,23)	OYHYEIOOJKQHBV-UHFFFAOYSA-N	168285	US9669031, 113 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,2&#8242;-indane]-1,1&#8242;,5-trione (Cpd. No. 113)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168285&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598809	373987039							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476244	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21Cc2ccccc2C1=O	InChI=1S/C19H12ClN5O3/c20-12-7-13(23-14-5-6-21-9-22-14)18(28)25-15(12)17(27)24-19(25)8-10-3-1-2-4-11(10)16(19)26/h1-7,9H,8H2,(H,24,27)(H,21,22,23)	OYHYEIOOJKQHBV-UHFFFAOYSA-N	168285	US9669031, 113 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,2&#8242;-indane]-1,1&#8242;,5-trione (Cpd. No. 113)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168285	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168285&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598809	373987039							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476245	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCc5ccc(F)cc45)n3c2=O)ncn1	InChI=1S/C24H22ClFN6O4/c1-23(2,3)36-22(35)30-18-10-17(27-11-28-18)29-16-9-15(25)19-20(33)31-24(32(19)21(16)34)7-6-12-4-5-13(26)8-14(12)24/h4-5,8-11H,6-7H2,1-3H3,(H,31,33)(H2,27,28,29,30,35)	QVIFDULUIUGQPN-UHFFFAOYSA-N	168286	US9669031, 114 6-((6-aminopyrimidin-4-yl)amino)-8-chloro-6&#8242;-fluoro-2&#8242;,3&#8242;-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,1&#8242;-indene]-1,5-dione hydrochloride (Cpd. No. 114)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168286&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118604430	373987040							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476246	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCc5ccc(F)cc45)n3c2=O)ncn1	InChI=1S/C24H22ClFN6O4/c1-23(2,3)36-22(35)30-18-10-17(27-11-28-18)29-16-9-15(25)19-20(33)31-24(32(19)21(16)34)7-6-12-4-5-13(26)8-14(12)24/h4-5,8-11H,6-7H2,1-3H3,(H,31,33)(H2,27,28,29,30,35)	QVIFDULUIUGQPN-UHFFFAOYSA-N	168286	US9669031, 114 6-((6-aminopyrimidin-4-yl)amino)-8-chloro-6&#8242;-fluoro-2&#8242;,3&#8242;-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,1&#8242;-indene]-1,5-dione hydrochloride (Cpd. No. 114)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168286	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168286&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604430	373987040							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476247	Clc1cc(Nc2ncncc2Cl)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C16H15Cl2N5O2/c17-9-6-11(21-13-10(18)7-19-8-20-13)15(25)23-12(9)14(24)22-16(23)4-2-1-3-5-16/h6-8H,1-5H2,(H,22,24)(H,19,20,21)	RIXAITOCBFYKSN-UHFFFAOYSA-N	168287	US9669031, 115 8-chloro-6-[(5-chloropyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 115)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168287&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598650	373987041							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476248	Clc1cc(Nc2ncncc2Cl)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C16H15Cl2N5O2/c17-9-6-11(21-13-10(18)7-19-8-20-13)15(25)23-12(9)14(24)22-16(23)4-2-1-3-5-16/h6-8H,1-5H2,(H,22,24)(H,19,20,21)	RIXAITOCBFYKSN-UHFFFAOYSA-N	168287	US9669031, 115 8-chloro-6-[(5-chloropyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 115)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168287	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168287&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598650	373987041							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476249	Cc1cc(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ncn1	InChI=1S/C17H18ClN5O2/c1-10-7-13(20-9-19-10)21-12-8-11(18)14-15(24)22-17(23(14)16(12)25)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H,19,20,21)	JHXOIXGVVIAHRL-UHFFFAOYSA-N	168288	US9669031, 116 8-chloro-6-[(6-methylpyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 116)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168288&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598712	373987042							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476250	Cc1cc(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ncn1	InChI=1S/C17H18ClN5O2/c1-10-7-13(20-9-19-10)21-12-8-11(18)14-15(24)22-17(23(14)16(12)25)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H,19,20,21)	JHXOIXGVVIAHRL-UHFFFAOYSA-N	168288	US9669031, 116 8-chloro-6-[(6-methylpyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 116)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168288	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168288&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598712	373987042							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476251	C[Si](C)(C)CCOCn1cnc2ncnc(Nc3cc(Cl)c4C(=O)NC5(CCCCC5)n4c3=O)c12	InChI=1S/C23H30ClN7O3Si/c1-35(2,3)10-9-34-14-30-13-27-19-18(30)20(26-12-25-19)28-16-11-15(24)17-21(32)29-23(31(17)22(16)33)7-5-4-6-8-23/h11-13H,4-10,14H2,1-3H3,(H,29,32)(H,25,26,28)	GCRMYHQANUBAMO-UHFFFAOYSA-N	168289	US9669031, 117 6&#8242;-((7H-purin-6-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 117)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168289&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			123745674	373987043							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476252	C[Si](C)(C)CCOCn1cnc2ncnc(Nc3cc(Cl)c4C(=O)NC5(CCCCC5)n4c3=O)c12	InChI=1S/C23H30ClN7O3Si/c1-35(2,3)10-9-34-14-30-13-27-19-18(30)20(26-12-25-19)28-16-11-15(24)17-21(32)29-23(31(17)22(16)33)7-5-4-6-8-23/h11-13H,4-10,14H2,1-3H3,(H,29,32)(H,25,26,28)	GCRMYHQANUBAMO-UHFFFAOYSA-N	168289	US9669031, 117 6&#8242;-((7H-purin-6-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 117)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168289	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168289&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			123745674	373987043							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476253	CC1(NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n12)C1CCCC1	InChI=1S/C21H24N6O3/c1-21(13-4-2-3-5-13)26-19(29)15-9-8-14(20(30)27(15)21)24-16-10-17(23-11-22-16)25-18(28)12-6-7-12/h8-13H,2-7H2,1H3,(H,26,29)(H2,22,23,24,25,28)	WYSSCWVPJCWZCU-UHFFFAOYSA-N	164608	US9669031, 118 6-[(6-aminopyrimidin-4-yl)amino]-3-cyclopentyl-3-methyl-1,5-dioxo-imidazo[1,5-a]pyridine-2-carbonitrile (Cpd. No. 118)::US9669031, 23 N-[6-[(3-cyclopentyl-3-methyl-1,5-dioxo-2H-imidazo[1,5-a]pyridin-6-yl)amino]pyrimidin-4-yl]cyclopropanecarboxamide (Cpd. No. 23)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=164608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=164608&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598558	373986953							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476254	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC(c4cccc(F)c4)n3c2=O)ncn1	InChI=1S/C22H20ClFN6O4/c1-22(2,3)34-21(33)28-16-9-15(25-10-26-16)27-14-8-13(23)17-19(31)29-18(30(17)20(14)32)11-5-4-6-12(24)7-11/h4-10,18H,1-3H3,(H,29,31)(H2,25,26,27,28,33)	HYSYLMUIQBYISU-UHFFFAOYSA-N	168291	US9669031, 119 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-3-(3-fluorophenyl)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 119)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168291	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168291&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604431	373987044							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476255	CC1(C)CCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C16H16ClN5O2/c1-15(2)4-5-16(15)21-13(23)12-9(17)7-10(14(24)22(12)16)20-11-3-6-18-8-19-11/h3,6-8H,4-5H2,1-2H3,(H,21,23)(H,18,19,20)	PRCYWYOEZGQIEL-UHFFFAOYSA-N	168292	US9669031, 120 8&#8242;-chloro-2,2-dimethyl-6&#8242;-(pyrimidin-4-ylamino)-2&#8242;H-spiro[cyclobutane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 120)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168292	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168292&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598826	373987045							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476256	CC(C)(C)OC(=O)Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CCC4(C)C)n3c2=O)ncn1	InChI=1S/C21H25ClN6O4/c1-19(2,3)32-18(31)26-14-9-13(23-10-24-14)25-12-8-11(22)15-16(29)27-21(28(15)17(12)30)7-6-20(21,4)5/h8-10H,6-7H2,1-5H3,(H,27,29)(H2,23,24,25,26,31)	CONOKRXDLLBKHQ-UHFFFAOYSA-N	168293	US9669031, 121 6&#8242;-((6-Aminopyrimidin-4-yl)amino)-8&#8242;-chloro-2,2-dimethyl-2&#8242;H-spiro[cyclobutane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 121)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168293	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168293&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604432	373987046							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476257	CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncnc(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)c1Cl	InChI=1S/C26H32Cl2N6O6/c1-24(2,3)39-22(37)33(23(38)40-25(4,5)6)19-16(28)18(29-13-30-19)31-15-12-14(27)17-20(35)32-26(34(17)21(15)36)10-8-7-9-11-26/h12-13H,7-11H2,1-6H3,(H,32,35)(H,29,30,31)	FFGQBLLFCOXEIN-UHFFFAOYSA-N	168295	US9669031, 122 6-[(6-amino-5-chloro-pyrimidin-4-yl)amino]-8-chloro-spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 122)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168295	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168295&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598722	373987047							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476258	Clc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C18H17ClN6O2/c19-11-8-12(23-15-10-4-7-20-14(10)21-9-22-15)17(27)25-13(11)16(26)24-18(25)5-2-1-3-6-18/h4,7-9H,1-3,5-6H2,(H,24,26)(H2,20,21,22,23)	PROJXFZMWIEQJQ-UHFFFAOYSA-N	168296	US9669031, 123 6&#8242;-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 123)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168296	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168296&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598573	373987048							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476259	CC1(C)NC(=O)c2c(Cl)cc(Nc3ncnc4ccncc34)c(=O)n12	InChI=1S/C16H13ClN6O2/c1-16(2)22-14(24)12-9(17)5-11(15(25)23(12)16)21-13-8-6-18-4-3-10(8)19-7-20-13/h3-7H,1-2H3,(H,22,24)(H,19,20,21)	IOKLADYJDHRJIK-UHFFFAOYSA-N	168297	US9669031, 124 8-chloro-3,3-dimethyl-6-(pyrido[4,3-d]pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 124)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168297	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168297&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598666	373987049							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476260	Cc1nccc(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)n1	InChI=1S/C17H18ClN5O2/c1-10-19-8-5-13(20-10)21-12-9-11(18)14-15(24)22-17(23(14)16(12)25)6-3-2-4-7-17/h5,8-9H,2-4,6-7H2,1H3,(H,22,24)(H,19,20,21)	GTMRQLZHPLNWIF-UHFFFAOYSA-N	168298	US9669031, 125 8&#8242;-chloro-6&#8242;-((2-methylpyrimidin-4-yl)amino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 125)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168298	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168298&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598808	373987050							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476261	Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CNCNC4)n3c2=O)ncn1	InChI=1S/C14H15ClN8O2/c15-7-1-8(21-10-2-9(16)19-6-20-10)13(25)23-11(7)12(24)22-14(23)3-17-5-18-4-14/h1-2,6,17-18H,3-5H2,(H,22,24)(H3,16,19,20,21)	QBAWPLVWTBJZJG-UHFFFAOYSA-N	168299	US9669031, 126 6-((6-aminopyrimidin-4-yl)amino)-8-chloro-2H-spiro[imidazo[1,5-a]pyridine-3,6&#8242;-[1,4]diazepane]-1,5-dione (Cpd. No. 126)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168299&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			134128221	373987051							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476262	Nc1cc(Nc2cc(Cl)c3C(=O)NC4(CNCNC4)n3c2=O)ncn1	InChI=1S/C14H15ClN8O2/c15-7-1-8(21-10-2-9(16)19-6-20-10)13(25)23-11(7)12(24)22-14(23)3-17-5-18-4-14/h1-2,6,17-18H,3-5H2,(H,22,24)(H3,16,19,20,21)	QBAWPLVWTBJZJG-UHFFFAOYSA-N	168299	US9669031, 126 6-((6-aminopyrimidin-4-yl)amino)-8-chloro-2H-spiro[imidazo[1,5-a]pyridine-3,6&#8242;-[1,4]diazepane]-1,5-dione (Cpd. No. 126)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168299	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168299&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			134128221	373987051							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476263	Clc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H16ClN7O2/c18-10-6-11(22-13-9-7-21-24-14(9)20-8-19-13)16(27)25-12(10)15(26)23-17(25)4-2-1-3-5-17/h6-8H,1-5H2,(H,23,26)(H2,19,20,21,22,24)	RWALTXNCWCAKGV-UHFFFAOYSA-N	168301	US9669031, 127 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 127)::US9669031, 145 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 145)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168301&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598677	373987052							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476264	Clc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H16ClN7O2/c18-10-6-11(22-13-9-7-21-24-14(9)20-8-19-13)16(27)25-12(10)15(26)23-17(25)4-2-1-3-5-17/h6-8H,1-5H2,(H,23,26)(H2,19,20,21,22,24)	RWALTXNCWCAKGV-UHFFFAOYSA-N	168301	US9669031, 127 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 127)::US9669031, 145 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 145)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168301&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598677	373987052							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476265	CN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)OC(C)(C)C)ncn3)c(=O)n21	InChI=1S/C21H26ClN7O4/c1-20(2,3)33-19(32)26-15-10-14(23-11-24-15)25-13-9-12(22)16-17(30)27-21(29(16)18(13)31)5-7-28(4)8-6-21/h9-11H,5-8H2,1-4H3,(H,27,30)(H2,23,24,25,26,32)	IYOBNWGZPFPIIQ-UHFFFAOYSA-N	168302	US9669031, 128 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-1&#8242;-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 128)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168302&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598755	373987053							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476266	CN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3cc(NC(=O)OC(C)(C)C)ncn3)c(=O)n21	InChI=1S/C21H26ClN7O4/c1-20(2,3)33-19(32)26-15-10-14(23-11-24-15)25-13-9-12(22)16-17(30)27-21(29(16)18(13)31)5-7-28(4)8-6-21/h9-11H,5-8H2,1-4H3,(H,27,30)(H2,23,24,25,26,32)	IYOBNWGZPFPIIQ-UHFFFAOYSA-N	168302	US9669031, 128 6-[(6-aminopyrimidin-4-yl)amino]-8-chloro-1&#8242;-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 128)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168302	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168302&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598755	373987053							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476267	CN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C16H17ClN6O2/c1-22-6-3-16(4-7-22)21-14(24)13-10(17)8-11(15(25)23(13)16)20-12-2-5-18-9-19-12/h2,5,8-9H,3-4,6-7H2,1H3,(H,21,24)(H,18,19,20)	ZRTRQXQCCPEDSY-UHFFFAOYSA-N	168303	US9669031, 129 8-chloro-1&#8242;-methyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 129)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168303&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598958	373987054							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476268	CN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C16H17ClN6O2/c1-22-6-3-16(4-7-22)21-14(24)13-10(17)8-11(15(25)23(13)16)20-12-2-5-18-9-19-12/h2,5,8-9H,3-4,6-7H2,1H3,(H,21,24)(H,18,19,20)	ZRTRQXQCCPEDSY-UHFFFAOYSA-N	168303	US9669031, 129 8-chloro-1&#8242;-methyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 129)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168303	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168303&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598958	373987054							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476269	CN1CCCC2(C1)NC(=O)c1c(C)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C17H20N6O2/c1-11-8-12(20-13-4-6-18-10-19-13)16(25)23-14(11)15(24)21-17(23)5-3-7-22(2)9-17/h4,6,8,10H,3,5,7,9H2,1-2H3,(H,21,24)(H,18,19,20)	CLZFXJFITWSDML-UHFFFAOYSA-N	168304	US9669031, 130 1&#8242;,8-dimethyl-6-(pyrimidin-4-ylamino)-2H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5-dione (Cpd. No. 130)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168304&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598923	373987055							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476270	CN1CCCC2(C1)NC(=O)c1c(C)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C17H20N6O2/c1-11-8-12(20-13-4-6-18-10-19-13)16(25)23-14(11)15(24)21-17(23)5-3-7-22(2)9-17/h4,6,8,10H,3,5,7,9H2,1-2H3,(H,21,24)(H,18,19,20)	CLZFXJFITWSDML-UHFFFAOYSA-N	168304	US9669031, 130 1&#8242;,8-dimethyl-6-(pyrimidin-4-ylamino)-2H-spiro[imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5-dione (Cpd. No. 130)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168304	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168304&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598923	373987055							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476271	O=c1c(Nc2ccncn2)ccc2C(=S)NC3(CCCCC3)n12	InChI=1S/C16H17N5OS/c22-15-11(19-13-6-9-17-10-18-13)4-5-12-14(23)20-16(21(12)15)7-2-1-3-8-16/h4-6,9-10H,1-3,7-8H2,(H,20,23)(H,17,18,19)	RKQOJQINEOWQTN-UHFFFAOYSA-N	168305	US9669031, 131 6&#8242;-(pyrimidin-4-ylamino)-1&#8242;-thioxo-1&#8242;,2&#8242;-dihydro-5&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-5&#8242;-one (Cpd. No. 131)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168305&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599033	373987056							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476272	O=c1c(Nc2ccncn2)ccc2C(=S)NC3(CCCCC3)n12	InChI=1S/C16H17N5OS/c22-15-11(19-13-6-9-17-10-18-13)4-5-12-14(23)20-16(21(12)15)7-2-1-3-8-16/h4-6,9-10H,1-3,7-8H2,(H,20,23)(H,17,18,19)	RKQOJQINEOWQTN-UHFFFAOYSA-N	168305	US9669031, 131 6&#8242;-(pyrimidin-4-ylamino)-1&#8242;-thioxo-1&#8242;,2&#8242;-dihydro-5&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-5&#8242;-one (Cpd. No. 131)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168305	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168305&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599033	373987056							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476273	Clc1cc(Nc2ccncn2)c(=S)n2c1C(=O)NC21CCCCC1	InChI=1S/C16H16ClN5OS/c17-10-8-11(20-12-4-7-18-9-19-12)15(24)22-13(10)14(23)21-16(22)5-2-1-3-6-16/h4,7-9H,1-3,5-6H2,(H,21,23)(H,18,19,20)	GRABHPQAWWXTSN-UHFFFAOYSA-N	168306	US9669031, 133 8&#8242;-chloro-6&#8242;-(pyrimidin-4-ylamino)-5&#8242;-thioxo-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-1&#8242;(5&#8242;H)-one (Cpd. No. 133)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168306	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168306&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598951	373987057							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476274	O=C1NC2(CCCCC2)n2c1c(cc(Nc1ccncn1)c2=O)-c1ccccc1	InChI=1S/C22H21N5O2/c28-20-19-16(15-7-3-1-4-8-15)13-17(25-18-9-12-23-14-24-18)21(29)27(19)22(26-20)10-5-2-6-11-22/h1,3-4,7-9,12-14H,2,5-6,10-11H2,(H,26,28)(H,23,24,25)	KPUDPFPDRISOPO-UHFFFAOYSA-N	168307	US9669031, 138 8-phenyl-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 138)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168307	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168307&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598595	373987058							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476275	Clc1cc(Nc2ncncc2C#N)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H15ClN6O2/c18-11-6-12(22-14-10(7-19)8-20-9-21-14)16(26)24-13(11)15(25)23-17(24)4-2-1-3-5-17/h6,8-9H,1-5H2,(H,23,25)(H,20,21,22)	JTGDAAJGSXVAJB-UHFFFAOYSA-N	168308	US9669031, 142 4-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidine-5-carbonitrile (Cpd. No. 142)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168308&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599105	373987059							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476276	Clc1cc(Nc2ncncc2C#N)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H15ClN6O2/c18-11-6-12(22-14-10(7-19)8-20-9-21-14)16(26)24-13(11)15(25)23-17(24)4-2-1-3-5-17/h6,8-9H,1-5H2,(H,23,25)(H,20,21,22)	JTGDAAJGSXVAJB-UHFFFAOYSA-N	168308	US9669031, 142 4-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidine-5-carbonitrile (Cpd. No. 142)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168308	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168308&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599105	373987059							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476277	Cn1cc(cn1)-c1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C20H20ClN7O2/c1-27-10-12(8-24-27)13-9-22-11-23-17(13)25-15-7-14(21)16-18(29)26-20(28(16)19(15)30)5-3-2-4-6-20/h7-11H,2-6H2,1H3,(H,26,29)(H,22,23,25)	HAHZCXCJVQDIIW-UHFFFAOYSA-N	168309	US9669031, 143 8&#8242;-chloro-6&#8242;-((5-(1-methyl-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 143)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168309&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118599137	373987060							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476278	Cn1cc(cn1)-c1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C20H20ClN7O2/c1-27-10-12(8-24-27)13-9-22-11-23-17(13)25-15-7-14(21)16-18(29)26-20(28(16)19(15)30)5-3-2-4-6-20/h7-11H,2-6H2,1H3,(H,26,29)(H,22,23,25)	HAHZCXCJVQDIIW-UHFFFAOYSA-N	168309	US9669031, 143 8&#8242;-chloro-6&#8242;-((5-(1-methyl-1H-pyrazol-4-yl)pyrimidin-4-yl)amino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 143)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168309	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168309&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599137	373987060							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476279	Clc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H16ClN7O2/c18-10-6-11(22-13-9-7-21-24-14(9)20-8-19-13)16(27)25-12(10)15(26)23-17(25)4-2-1-3-5-17/h6-8H,1-5H2,(H,23,26)(H2,19,20,21,22,24)	RWALTXNCWCAKGV-UHFFFAOYSA-N	168301	US9669031, 127 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 127)::US9669031, 145 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 145)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168301&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598677	373987052							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476280	Clc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H16ClN7O2/c18-10-6-11(22-13-9-7-21-24-14(9)20-8-19-13)16(27)25-12(10)15(26)23-17(25)4-2-1-3-5-17/h6-8H,1-5H2,(H,23,26)(H2,19,20,21,22,24)	RWALTXNCWCAKGV-UHFFFAOYSA-N	168301	US9669031, 127 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 127)::US9669031, 145 6&#8242;-((1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 145)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168301	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168301&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598677	373987052							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476281	CC(C)C(=O)N(COCC[Si](C)(C)C)c1ncnc2n(COCC[Si](C)(C)C)nnc12	InChI=1S/C20H38N6O3Si2/c1-16(2)20(27)25(14-28-9-11-30(3,4)5)18-17-19(22-13-21-18)26(24-23-17)15-29-10-12-31(6,7)8/h13,16H,9-12,14-15H2,1-8H3	DMFRKWDLXLCZCZ-UHFFFAOYSA-N	168311	US9669031, 146 8-chloro-6-(3H-triazolo[4,5-d]pyrimidin-7-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 146)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168311&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			131736067	373987061							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476282	CC(C)C(=O)N(COCC[Si](C)(C)C)c1ncnc2n(COCC[Si](C)(C)C)nnc12	InChI=1S/C20H38N6O3Si2/c1-16(2)20(27)25(14-28-9-11-30(3,4)5)18-17-19(22-13-21-18)26(24-23-17)15-29-10-12-31(6,7)8/h13,16H,9-12,14-15H2,1-8H3	DMFRKWDLXLCZCZ-UHFFFAOYSA-N	168311	US9669031, 146 8-chloro-6-(3H-triazolo[4,5-d]pyrimidin-7-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 146)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168311	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168311&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			131736067	373987061							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476283	CCCC1(CCC)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H20ClN5O2/c1-3-6-17(7-4-2)22-15(24)14-11(18)9-12(16(25)23(14)17)21-13-5-8-19-10-20-13/h5,8-10H,3-4,6-7H2,1-2H3,(H,22,24)(H,19,20,21)	OLAIQAGCMCSWJI-UHFFFAOYSA-N	168312	US9669031, 151 8-chloro-3,3-dipropyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 151)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168312	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168312&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598775	373987062							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476284	COC(=O)CC1(CC(=O)OC)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H16ClN5O6/c1-28-12(24)6-17(7-13(25)29-2)22-15(26)14-9(18)5-10(16(27)23(14)17)21-11-3-4-19-8-20-11/h3-5,8H,6-7H2,1-2H3,(H,22,26)(H,19,20,21)	MARYFTQFXRHJEJ-UHFFFAOYSA-N	168316	US9669031, 153 8-chloro-3,3-bis(2-hydroxyethyl)-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 153)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168316	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168316&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599006	373987063							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476285	CC(C)(C)[Si](C)(C)OCCN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C23H33ClN6O3Si/c1-22(2,3)34(4,5)33-13-12-29-10-7-23(8-11-29)28-20(31)19-16(24)14-17(21(32)30(19)23)27-18-6-9-25-15-26-18/h6,9,14-15H,7-8,10-13H2,1-5H3,(H,28,31)(H,25,26,27)	UUNAQVROHMBKNZ-UHFFFAOYSA-N	168317	US9669031, 155 8-chloro-1&#8242;-(2-hydroxyethyl)-6-(pyrimidin-4-ylamino)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 155)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168317	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168317&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			123564700	373987064							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476286	FC(F)CN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C17H17ClF2N6O2/c18-10-7-11(23-13-1-4-21-9-22-13)16(28)26-14(10)15(27)24-17(26)2-5-25(6-3-17)8-12(19)20/h1,4,7,9,12H,2-3,5-6,8H2,(H,24,27)(H,21,22,23)	JPAMTTMIRNDNGO-UHFFFAOYSA-N	168319	US9669031, 156 8-chloro-1&#8242;-(2,2-difluoroethyl)-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 156)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168319	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168319&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598678	373987065							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476287	FC(F)(F)CN1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C17H16ClF3N6O2/c18-10-7-11(24-12-1-4-22-9-23-12)15(29)27-13(10)14(28)25-16(27)2-5-26(6-3-16)8-17(19,20)21/h1,4,7,9H,2-3,5-6,8H2,(H,25,28)(H,22,23,24)	BCAUWYUSLSHUKH-UHFFFAOYSA-N	168321	US9669031, 157 8-chloro-6-(pyrimidin-4-ylamino)-1&#8242;-(2,2,2-trifluoroethyl)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 157)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168321	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168321&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598660	373987066							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476288	CN1C2CCC1CC1(C2)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C18H19ClN6O2/c1-24-10-2-3-11(24)8-18(7-10)23-16(26)15-12(19)6-13(17(27)25(15)18)22-14-4-5-20-9-21-14/h4-6,9-11H,2-3,7-8H2,1H3,(H,23,26)(H,20,21,22)	AJIAZDPEWUHLNA-UHFFFAOYSA-N	168323	US9669031, 158 8&#8242;-chloro-8-methyl-6&#8242;-(pyrimidin-4-ylamino)-2&#8242;H-8-azaspiro[bicyclo[3.2.1]octane-3,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 158)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168323	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168323&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599027	373987067							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476289	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCN(CC#N)CC1	InChI=1S/C17H16ClN7O2/c18-11-9-12(22-13-1-5-20-10-21-13)16(27)25-14(11)15(26)23-17(25)2-6-24(7-3-17)8-4-19/h1,5,9-10H,2-3,6-8H2,(H,23,26)(H,20,21,22)	YGUAWOGUKVTWBA-UHFFFAOYSA-N	168325	US9669031, 160 2-(8-chloro-1,5-dioxo-6-(pyrimidin-4-ylamino)-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidin]-1&#8242;-yl)acetonitrile (Cpd. No. 160)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168325	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168325&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598758	373987068							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476290	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCN(CC1)c1ccncn1	InChI=1S/C19H17ClN8O2/c20-12-9-13(25-14-1-5-21-10-23-14)18(30)28-16(12)17(29)26-19(28)3-7-27(8-4-19)15-2-6-22-11-24-15/h1-2,5-6,9-11H,3-4,7-8H2,(H,26,29)(H,21,23,25)	HXXLSYFKZGNLMP-UHFFFAOYSA-N	168327	US9669031, 161 8-chloro-1&#8242;-(pyrimidin-4-yl)-6-(pyrimidin-4-ylamino)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 161)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168327	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168327&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599088	373987069							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476291	CN(N1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21)C(=O)OC(C)(C)C	InChI=1S/C21H26ClN7O4/c1-20(2,3)33-19(32)27(4)28-9-6-21(7-10-28)26-17(30)16-13(22)11-14(18(31)29(16)21)25-15-5-8-23-12-24-15/h5,8,11-12H,6-7,9-10H2,1-4H3,(H,26,30)(H,23,24,25)	UWOMHLCMEWOFFY-UHFFFAOYSA-N	168328	US9669031, 162 8-chloro-4&#8242;-(methylamino)-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 162)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168328	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168328&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			122659719	373987070							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476292	CC(=O)N1CCC2(CC1)NC(=O)c1c(Cl)cc(Nc3ccncn3)c(=O)n21	InChI=1S/C17H17ClN6O3/c1-10(25)23-6-3-17(4-7-23)22-15(26)14-11(18)8-12(16(27)24(14)17)21-13-2-5-19-9-20-13/h2,5,8-9H,3-4,6-7H2,1H3,(H,22,26)(H,19,20,21)	FDUKGUHPTGOCIY-UHFFFAOYSA-N	168330	US9669031, 163 1&#8242;-acetyl-8-chloro-6-(pyrimidin-4-ylamino)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 163)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168330	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168330&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598994	373987071							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476293	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCN(CC1)C#N	InChI=1S/C16H14ClN7O2/c17-10-7-11(21-12-1-4-19-9-20-12)15(26)24-13(10)14(25)22-16(24)2-5-23(8-18)6-3-16/h1,4,7,9H,2-3,5-6H2,(H,22,25)(H,19,20,21)	GKABENCNXKROOG-UHFFFAOYSA-N	168331	US9669031, 164 8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-6&#8242;-(pyrimidin-4-ylamino)-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-4-carbonitrile (Cpd. No. 164)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168331	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168331&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			122659722	373987072							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476294	CC1(C)NC(=O)c2c(Cl)cc(Nc3ncnc4cnccc34)c(=O)n12	InChI=1S/C16H13ClN6O2/c1-16(2)22-14(24)12-9(17)5-10(15(25)23(12)16)21-13-8-3-4-18-6-11(8)19-7-20-13/h3-7H,1-2H3,(H,22,24)(H,19,20,21)	SXKIBLJFZKDDCP-UHFFFAOYSA-N	168332	US9669031, 165 8-chloro-3,3-dimethyl-6-(pyrido[3,4-d]pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 165)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168332&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598900	373987073							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476295	CC1(C)NC(=O)c2c(Cl)cc(Nc3ncnc4cnccc34)c(=O)n12	InChI=1S/C16H13ClN6O2/c1-16(2)22-14(24)12-9(17)5-10(15(25)23(12)16)21-13-8-3-4-18-6-11(8)19-7-20-13/h3-7H,1-2H3,(H,22,24)(H,19,20,21)	SXKIBLJFZKDDCP-UHFFFAOYSA-N	168332	US9669031, 165 8-chloro-3,3-dimethyl-6-(pyrido[3,4-d]pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 165)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168332	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168332&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598900	373987073							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476296	Fc1c(NC(=O)C2CC2)ncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C20H20ClFN6O3/c21-11-8-12(19(31)28-14(11)18(30)27-20(28)6-2-1-3-7-20)25-15-13(22)16(24-9-23-15)26-17(29)10-4-5-10/h8-10H,1-7H2,(H,27,30)(H2,23,24,25,26,29)	CJQLCXFBSXSBMA-UHFFFAOYSA-N	168333	US9669031, 169 6&#8242;-((6-amino-5-fluoropyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 169)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168333	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168333&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598992	373987074							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476297	CN1CCCC2(C1)NC(=O)c1c(C)cc(Nc3cc(NC(=O)OC(C)(C)C)ncn3)c(=O)n21	InChI=1S/C22H29N7O4/c1-13-9-14(25-15-10-16(24-12-23-15)26-20(32)33-21(2,3)4)19(31)29-17(13)18(30)27-22(29)7-6-8-28(5)11-22/h9-10,12H,6-8,11H2,1-5H3,(H,27,30)(H2,23,24,25,26,32)	XVIIZNRNNKVIGD-UHFFFAOYSA-N	168335	US9669031, 170 6-[(6-aminopyrimidin-4-yl)amino]-1&#8242;,8-dimethyl-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5-dione (Cpd. No. 170)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168335	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168335&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118604445	373987075							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476298	CN1CCCC2(C1)NC(=O)c1c(C)cc(Nc3cc(NC(=O)OC(C)(C)C)ncn3)c(=O)n21	InChI=1S/C22H29N7O4/c1-13-9-14(25-15-10-16(24-12-23-15)26-20(32)33-21(2,3)4)19(31)29-17(13)18(30)27-22(29)7-6-8-28(5)11-22/h9-10,12H,6-8,11H2,1-5H3,(H,27,30)(H2,23,24,25,26,32)	XVIIZNRNNKVIGD-UHFFFAOYSA-N	168335	US9669031, 170 6-[(6-aminopyrimidin-4-yl)amino]-1&#8242;,8-dimethyl-spiro[2H-imidazo[1,5-a]pyridine-3,3&#8242;-piperidine]-1,5-dione (Cpd. No. 170)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168335	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168335&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604445	373987075							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476299	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476300	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C13H12ClN5O2/c1-13(2)18-11(20)10-7(14)5-8(12(21)19(10)13)17-9-3-4-15-6-16-9/h3-6H,1-2H3,(H,18,20)(H,15,16,17)	VMPOUPXTRIFPLU-UHFFFAOYSA-N	168216	US9669031, 181 3,3-dimethyl-1,5-dioxo-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-8-carbonitrile (Cpd. No. 181)::US9669031, 47 8-chloro-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 47)::US9669031, 71 8-ethyl-3,3-dimethyl-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 71)::US9669031, 79 3,3-dimethyl-6-(pyrimidin-4-ylamino)-8-vinyl-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 79)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168216&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598634	373986979							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476301	COc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C17H18ClN5O3/c1-26-12-8-19-9-20-14(12)21-11-7-10(18)13-15(24)22-17(23(13)16(11)25)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H,19,20,21)	YEZVBLAHPOQECG-UHFFFAOYSA-N	168338	US9669031, 187 8-chloro-6-[(5-methoxypyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 187)	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168338&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			118598973	373987076							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476302	COc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C17H18ClN5O3/c1-26-12-8-19-9-20-14(12)21-11-7-10(18)13-15(24)22-17(23(13)16(11)25)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H,19,20,21)	YEZVBLAHPOQECG-UHFFFAOYSA-N	168338	US9669031, 187 8-chloro-6-[(5-methoxypyrimidin-4-yl)amino]spiro[2H-imidazo[1,5-a]pyridine-3,1&#8242;-cyclohexane]-1,5-dione (Cpd. No. 187)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168338	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168338&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598973	373987076							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476303	CCc1c(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ncnc1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C28H37ClN6O6/c1-8-16-20(30-15-31-21(16)34(24(38)40-26(2,3)4)25(39)41-27(5,6)7)32-18-14-17(29)19-22(36)33-28(35(19)23(18)37)12-10-9-11-13-28/h14-15H,8-13H2,1-7H3,(H,33,36)(H,30,31,32)	XDWZUHPHHMKABY-UHFFFAOYSA-N	168339	US9669031, 188 6&#8242;-((6-amino-5-ethylpyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 188)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168339	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168339&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598583	373987077							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476304	CC(C)c1c(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ncnc1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C29H39ClN6O6/c1-16(2)19-21(31-15-32-22(19)35(25(39)41-27(3,4)5)26(40)42-28(6,7)8)33-18-14-17(30)20-23(37)34-29(36(20)24(18)38)12-10-9-11-13-29/h14-16H,9-13H2,1-8H3,(H,34,37)(H,31,32,33)	PQDAELROGFSJPN-UHFFFAOYSA-N	168340	US9669031, 189 6&#8242;-((6-amino-5-isopropylpyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 189)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168340	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168340&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598960	373987078							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476305	Clc1cc(-n2ccc3cncnc23)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C18H16ClN5O2/c19-12-8-13(23-7-4-11-9-20-10-21-15(11)23)17(26)24-14(12)16(25)22-18(24)5-2-1-3-6-18/h4,7-10H,1-3,5-6H2,(H,22,25)	UMOMDELPDWYEPB-UHFFFAOYSA-N	168341	US9669031, 190 8&#8242;-chloro-6&#8242;-(7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 190)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168341	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168341&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598850	373987079							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476306	FC(F)(F)C1CCCCC11NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C17H15ClF3N5O2/c18-9-7-10(24-12-4-6-22-8-23-12)15(28)26-13(9)14(27)25-16(26)5-2-1-3-11(16)17(19,20)21/h4,6-8,11H,1-3,5H2,(H,25,27)(H,22,23,24)	YGLZKYMIRSLUGB-UHFFFAOYSA-N	168342	US9669031, 191 8&#8242;-chloro-6&#8242;-(pyrimidin-4-ylamino)-2-(trifluoromethyl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 191)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168342	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168342&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598857	373987080							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476307	CC(C)=CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n12	InChI=1S/C16H16ClN5O2/c1-9(2)7-16(3)21-14(23)13-10(17)6-11(15(24)22(13)16)20-12-4-5-18-8-19-12/h4-8H,1-3H3,(H,21,23)(H,18,19,20)	KDEUFEMJUSWRRR-UHFFFAOYSA-N	168343	US9669031, 192 8-chloro-3-methyl-3-(2-methylprop-1-enyl)-6-(pyrimidin-4-ylamino)-2H-imidazo[1,5-a]pyridine-1,5-dione (Cpd. No. 192)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168343	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168343&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598692	373987081							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476308	Cc1c(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ncnc1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C27H35ClN6O6/c1-15-19(29-14-30-20(15)33(23(37)39-25(2,3)4)24(38)40-26(5,6)7)31-17-13-16(28)18-21(35)32-27(34(18)22(17)36)11-9-8-10-12-27/h13-14H,8-12H2,1-7H3,(H,32,35)(H,29,30,31)	KPAYAMGNQYYGGQ-UHFFFAOYSA-N	168344	US9669031, 193 6&#8242;-((6-amino-5-methylpyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 193)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168344	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168344&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598830	373987082							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476309	CCc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C18H20ClN5O2/c1-2-11-9-20-10-21-15(11)22-13-8-12(19)14-16(25)23-18(24(14)17(13)26)6-4-3-5-7-18/h8-10H,2-7H2,1H3,(H,23,25)(H,20,21,22)	FTAOPKOZQIHAEA-UHFFFAOYSA-N	168345	US9669031, 194 8&#8242;-chloro-6&#8242;-((5-ethylpyrimidin-4-yl)amino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 194)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168345	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168345&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598817	373987083							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476310	COc1c(Nc2cc(Cl)c3C(=O)NC4(CCCCC4)n3c2=O)ncnc1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C27H35ClN6O7/c1-25(2,3)40-23(37)33(24(38)41-26(4,5)6)20-18(39-7)19(29-14-30-20)31-16-13-15(28)17-21(35)32-27(34(17)22(16)36)11-9-8-10-12-27/h13-14H,8-12H2,1-7H3,(H,32,35)(H,29,30,31)	XNYXSJJZNIYWHO-UHFFFAOYSA-N	168346	US9669031, 195 6&#8242;-((6-amino-5-methoxypyrimidin-4-yl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 195)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168346	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168346&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599098	373987084							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476311	CCOc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C18H20ClN5O3/c1-2-27-13-9-20-10-21-15(13)22-12-8-11(19)14-16(25)23-18(24(14)17(12)26)6-4-3-5-7-18/h8-10H,2-7H2,1H3,(H,23,25)(H,20,21,22)	WQIYRPKSOUHJTO-UHFFFAOYSA-N	168347	US9669031, 196 8&#8242;-chloro-6&#8242;-((5-ethoxypyrimidin-4-yl)amino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 196)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168347	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168347&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598852	373987085							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476312	CC(C)Oc1cncnc1Nc1cc(Cl)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C19H22ClN5O3/c1-11(2)28-14-9-21-10-22-16(14)23-13-8-12(20)15-17(26)24-19(25(15)18(13)27)6-4-3-5-7-19/h8-11H,3-7H2,1-2H3,(H,24,26)(H,21,22,23)	DPXADVRYWJJDPN-UHFFFAOYSA-N	168348	US9669031, 197 8&#8242;-chloro-6&#8242;-((5-isopropoxypyrimidin-4-yl)amino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 197)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168348	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168348&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599080	373987086							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476313	Clc1cc(Nc2ccncn2)c(=O)n2c1C(=O)N(C1CCCC1)C21CCCCC1	InChI=1S/C21H24ClN5O2/c22-15-12-16(25-17-8-11-23-13-24-17)19(28)27-18(15)20(29)26(14-6-2-3-7-14)21(27)9-4-1-5-10-21/h8,11-14H,1-7,9-10H2,(H,23,24,25)	LMCTXYQXVNAQOM-UHFFFAOYSA-N	168349	US9669031, 198 8&#8242;-chloro-2&#8242;-cyclopentyl-6&#8242;-(pyrimidin-4-ylamino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 198)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168349	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168349&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598774	373987087							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476314	CN(c1cc(NC(=O)C2CC2)ncn1)c1cc(Cl)c2C(=O)NC3(CCCC3)n2c1=O	InChI=1S/C20H21ClN6O3/c1-26(15-9-14(22-10-23-15)24-17(28)11-4-5-11)13-8-12(21)16-18(29)25-20(6-2-3-7-20)27(16)19(13)30/h8-11H,2-7H2,1H3,(H,25,29)(H,22,23,24,28)	RCLLPLWMZMYKGV-UHFFFAOYSA-N	168350	US9669031, 200 6&#8242;-((6-aminopyrimidin-4-yl)(methyl)amino)-8&#8242;-chloro-2&#8242;H-spiro[cyclopentane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 200)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168350	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168350&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599057	373987088							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476315	O=C1NC2(CCCCC2)n2c1c(cc(Nc1ccncn1)c2=O)C1CCOCC1	InChI=1S/C21H25N5O3/c27-19-18-15(14-5-10-29-11-6-14)12-16(24-17-4-9-22-13-23-17)20(28)26(18)21(25-19)7-2-1-3-8-21/h4,9,12-14H,1-3,5-8,10-11H2,(H,25,27)(H,22,23,24)	BSNYAQFBPWYJAU-UHFFFAOYSA-N	168351	US9669031, 201 6&#8242;-(pyrimidin-4-ylamino)-8&#8242;-(tetrahydro-2H-pyran-4-yl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 201)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168351	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168351&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599092	373987089							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476316	COc1c(Nc2cc(C)c3C(=O)NC4(CCCCC4)n3c2=O)ncnc1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C28H38N6O7/c1-16-14-17(23(36)34-18(16)22(35)32-28(34)12-10-9-11-13-28)31-20-19(39-8)21(30-15-29-20)33(24(37)40-26(2,3)4)25(38)41-27(5,6)7/h14-15H,9-13H2,1-8H3,(H,32,35)(H,29,30,31)	VBHCGXYFGTZHNM-UHFFFAOYSA-N	168352	US9669031, 202 6&#8242;-((6-amino-5-hydroxypyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 202)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168352	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168352&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598639	373987090							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476317	COc1nc(Nc2cc(C)c3C(=O)NC4(CCCCC4)n3c2=O)cc(n1)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C28H38N6O7/c1-16-14-17(22(36)34-20(16)21(35)32-28(34)12-10-9-11-13-28)29-18-15-19(31-23(30-18)39-8)33(24(37)40-26(2,3)4)25(38)41-27(5,6)7/h14-15H,9-13H2,1-8H3,(H,32,35)(H,29,30,31)	SUUUUSDWPANRCS-UHFFFAOYSA-N	168353	US9669031, 203 6&#8242;-((6-amino-2-hydroxypyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 203)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168353	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168353&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598697	373987091							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476318	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1O	InChI=1S/C17H20N6O3/c1-9-6-10(21-13-7-12(18)19-8-20-13)16(26)23-14(9)15(25)22-17(23)5-3-2-4-11(17)24/h6-8,11,24H,2-5H2,1H3,(H,22,25)(H3,18,19,20,21)	LKVHJCZVOXGHLL-UHFFFAOYSA-N	168354	US9669031, 204 6&#8242;-((6-aminopyrimidin-4-yl)amino)-2-hydroxy-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 204)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168354	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168354&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599063	373987092							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476319	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCC(O)CC1	InChI=1S/C17H20N6O3/c1-9-6-11(21-13-7-12(18)19-8-20-13)16(26)23-14(9)15(25)22-17(23)4-2-10(24)3-5-17/h6-8,10,24H,2-5H2,1H3,(H,22,25)(H3,18,19,20,21)	KFNYRNPXQICPOT-UHFFFAOYSA-N	168355	US9669031, 206 6&#8242;-((6-aminopyrimidin-4-yl)amino)-4-hydroxy-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 206)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168355	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168355&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598799	373987093							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476320	Clc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C20H21ClN6O3/c21-12-8-13(24-14-9-15(23-10-22-14)25-17(28)11-4-5-11)19(30)27-16(12)18(29)26-20(27)6-2-1-3-7-20/h8-11H,1-7H2,(H,26,29)(H2,22,23,24,25,28)	RLDAVKBTPHGEED-UHFFFAOYSA-N	168214	US9669031, 207 6&#8242;-((6-aminopyrimidin-4-yl)amino)-8&#8242;-(hydroxymethyl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 207)::US9669031, 45 N-(6-((8&#8242;-chloro-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidin-4-yl)cyclopropanecarboxamide (Cpd. No. 45)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168214&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598693	373986977							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476321	Cc1cc(Nc2ncncc2C2CC2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C20H23N5O2/c1-12-9-15(23-17-14(13-5-6-13)10-21-11-22-17)19(27)25-16(12)18(26)24-20(25)7-3-2-4-8-20/h9-11,13H,2-8H2,1H3,(H,24,26)(H,21,22,23)	QNUJICWWDQQWOG-UHFFFAOYSA-N	168357	US9669031, 208 6&#8242;-((5-cyclopropylpyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 208)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168357	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168357&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599104	373987094							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476322	Cc1cc(C(=O)c2ccncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C18H18N4O3/c1-11-9-12(15(23)13-5-8-19-10-20-13)17(25)22-14(11)16(24)21-18(22)6-3-2-4-7-18/h5,8-10H,2-4,6-7H2,1H3,(H,21,24)	PARJLDDHZBXSGW-UHFFFAOYSA-N	168359	US9669031, 211 8&#8242;-methyl-6&#8242;-(pyrimidine-4-carbonyl)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 211)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168359	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168359&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599084	373987095							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476323	CC(C)Cn1c(C(N)=O)c(Cl)cc(Nc2cc(N)ncn2)c1=O	InChI=1S/C14H17ClN6O2/c1-7(2)5-21-12(13(17)22)8(15)3-9(14(21)23)20-11-4-10(16)18-6-19-11/h3-4,6-7H,5H2,1-2H3,(H2,17,22)(H3,16,18,19,20)	VKBPOTMIGNJXPK-UHFFFAOYSA-N	168361	US9669031, 213 5-((6-aminopyrimidin-4-yl)amino)-3-chloro-1-isobutyl-6-oxo-1,6-dihydropyridine-2-carboxamide (Cpd. No. 213)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168361	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168361&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599072	373987096							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476324	CCOC(=O)c1c(Cl)cc(Nc2cc(NC(=O)OC(C)(C)C)ncn2)c(=O)n1Cc1ccc(OC)cc1	InChI=1S/C25H28ClN5O6/c1-6-36-23(33)21-17(26)11-18(22(32)31(21)13-15-7-9-16(35-5)10-8-15)29-19-12-20(28-14-27-19)30-24(34)37-25(2,3)4/h7-12,14H,6,13H2,1-5H3,(H2,27,28,29,30,34)	VUWLWIVEUFNTIG-UHFFFAOYSA-N	168362	US9669031, 214 5-((6-aminopyrimidin-4-yl)amino)-3-chloro-6-oxo-1,6-dihydropyridine-2-carboxamide (Cpd. No. 214)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168362	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168362&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599126	373987097							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476325	O=C1NC2(CCCCC2)n2c1ncc(Nc1ccncn1)c2=O	InChI=1S/C15H16N6O2/c22-13-12-17-8-10(19-11-4-7-16-9-18-11)14(23)21(12)15(20-13)5-2-1-3-6-15/h4,7-9H,1-3,5-6H2,(H,20,22)(H,16,18,19)	QYPSJKYTNHCYEU-UHFFFAOYSA-N	168363	US9669031, 215 3&#8242;-(pyrimidin-4-ylamino)-4&#8242;H-spiro[cyclohexane-1,6&#8242;-imidazo[1,5-a]pyrimidine]-4&#8242;,8&#8242;(7&#8242;H)-dione (Cpd. No. 215)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168363	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168363&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598820	373987098							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476326	Cc1nc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C16H18N6O2/c1-10-12-14(23)21-16(6-3-2-4-7-16)22(12)15(24)13(19-10)20-11-5-8-17-9-18-11/h5,8-9H,2-4,6-7H2,1H3,(H,21,23)(H,17,18,19,20)	WYWJFSQDCDGCDW-UHFFFAOYSA-N	168364	US9669031, 216 8&#8242;-methyl-6&#8242;-(pyrimidin-4-ylamino)-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyrazine]-1&#8242;,5&#8242;-dione (Cpd. No. 216)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168364	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168364&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599010	373987099							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476327	Cc1cc(Nc2cc(N)ncn2)c(=O)n2CCCNC(=O)c12	InChI=1S/C14H16N6O2/c1-8-5-9(19-11-6-10(15)17-7-18-11)14(22)20-4-2-3-16-13(21)12(8)20/h5-7H,2-4H2,1H3,(H,16,21)(H3,15,17,18,19)	NJFDWCLIMKDPRP-UHFFFAOYSA-N	168365	US9669031, 217 8-((6-aminopyrimidin-4-yl)amino)-10-methyl-2,3,4,5-tetrahydropyrido[1,2-a][1,4]diazepine-1,7-dione (Cpd. No. 217)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168365	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168365&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599020	373987100							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476328	Cc1cc(Nc2cc(N)[n+]([O-])cn2)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H20N6O3/c1-10-7-11(20-13-8-12(18)22(26)9-19-13)16(25)23-14(10)15(24)21-17(23)5-3-2-4-6-17/h7-9H,2-6,18H2,1H3,(H,19,20)(H,21,24)	ANBHCSJRQKLQKN-UHFFFAOYSA-N	168366	US9669031, 218 Synthesis 6-amino-4-((8&#8242;-methyl-1&#8242;,5&#8242;-dioxo-1&#8242;,5&#8242;-dihydro-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridin]-6&#8242;-yl)amino)pyrimidine 1-oxide (Cpd. No. 218)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>100						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168366	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168366&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599082	373987101							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476329	CN1CCC2(CC1)NC(=O)c1c(C)cc(Nc3cc(ncn3)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c(=O)n21	InChI=1S/C27H37N7O6/c1-16-13-17(22(36)34-20(16)21(35)31-27(34)9-11-32(8)12-10-27)30-18-14-19(29-15-28-18)33(23(37)39-25(2,3)4)24(38)40-26(5,6)7/h13-15H,9-12H2,1-8H3,(H,31,35)(H,28,29,30)	JCVPTSUNQRSFSX-UHFFFAOYSA-N	168367	US9669031, 219 6-((6-aminopyrimidin-4-yl)amino)-1&#8242;,8-dimethyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione hydrochloride (Cpd. No. 219)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168367	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168367&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598757	373987102							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476330	CN1CCC2(CC1)NC(=O)c1c(C)cc(Nc3ncnc(NC(=O)C4CC4)c3C)c(=O)n21	InChI=1S/C22H27N7O3/c1-12-10-15(25-17-13(2)18(24-11-23-17)26-19(30)14-4-5-14)21(32)29-16(12)20(31)27-22(29)6-8-28(3)9-7-22/h10-11,14H,4-9H2,1-3H3,(H,27,31)(H2,23,24,25,26,30)	UQWMIPRSEQZZOB-UHFFFAOYSA-N	168368	US9669031, 220 6-((6-amino-5-methylpyrimidin-4-yl)amino)-1&#8242;,8-dimethyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 220)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168368	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168368&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598914	373987103							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476331	Cc1cc(Nc2ncnc(NC(=O)C3CC3)c2C)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C22H26N6O3/c1-12-10-15(21(31)28-16(12)20(30)27-22(28)8-4-3-5-9-22)25-17-13(2)18(24-11-23-17)26-19(29)14-6-7-14/h10-11,14H,3-9H2,1-2H3,(H,27,30)(H2,23,24,25,26,29)	XSZKLMJZKJJGMM-UHFFFAOYSA-N	168369	US9669031, 222 6&#8242;-((6-amino-5-methylpyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 222)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168369	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168369&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604471	373987104							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476332	Cc1cc(Nc2ncnc(N)c2Cl)c(=O)n2c1C(=O)NC21CCCCC1	InChI=1S/C17H19ClN6O2/c1-9-7-10(22-14-11(18)13(19)20-8-21-14)16(26)24-12(9)15(25)23-17(24)5-3-2-4-6-17/h7-8H,2-6H2,1H3,(H,23,25)(H3,19,20,21,22)	OKPFQOBYVLLKMT-UHFFFAOYSA-N	168370	US9669031, 223 6&#8242;-((6-amino-5-chloropyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione hydrochloride (Cpd. No. 223)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168370	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168370&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599013	373987105							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476333	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCN(CC#N)CC1	InChI=1S/C18H20N8O2/c1-11-8-12(23-14-9-13(20)21-10-22-14)17(28)26-15(11)16(27)24-18(26)2-5-25(6-3-18)7-4-19/h8-10H,2-3,5-7H2,1H3,(H,24,27)(H3,20,21,22,23)	ISFFLIIQAAGFPO-UHFFFAOYSA-N	168371	US9669031, 225 2-(6-((6-aminopyrimidin-4-yl)amino)-8-methyl-1,5-dioxo-1,5-dihydro-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidin]-1&#8242;-yl)acetonitrile (Cpd. No. 225)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168371	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168371&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598858	373987106							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476334	Cc1cc(Nc2cc(ncn2)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCN(CC(F)F)CC1	InChI=1S/C28H37F2N7O6/c1-16-12-17(23(39)37-21(16)22(38)34-28(37)8-10-35(11-9-28)14-18(29)30)33-19-13-20(32-15-31-19)36(24(40)42-26(2,3)4)25(41)43-27(5,6)7/h12-13,15,18H,8-11,14H2,1-7H3,(H,34,38)(H,31,32,33)	DQFBLHZOUVFGBO-UHFFFAOYSA-N	168372	US9669031, 226 6-((6-aminopyrimidin-4-yl)amino)-1&#8242;-(2,2-difluoroethyl)-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 226)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168372	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168372&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599086	373987107							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476335	COc1cncnc1Nc1cc(C)c2C(=O)NC3(CCN(CC(F)F)CC3)n2c1=O	InChI=1S/C19H22F2N6O3/c1-11-7-12(24-16-13(30-2)8-22-10-23-16)18(29)27-15(11)17(28)25-19(27)3-5-26(6-4-19)9-14(20)21/h7-8,10,14H,3-6,9H2,1-2H3,(H,25,28)(H,22,23,24)	JCPXEYZKEMMQKA-UHFFFAOYSA-N	168373	US9669031, 230 1&#8242;-(2,2-difluoroethyl)-6-((5-methoxypyrimidin-4-yl)amino)-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 230)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168373	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168373&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598842	373987108							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476336	COc1c(NC(=O)C2CC2)ncnc1Nc1cc(C)c2C(=O)NC3(CCCCC3)n2c1=O	InChI=1S/C22H26N6O4/c1-12-10-14(21(31)28-15(12)20(30)27-22(28)8-4-3-5-9-22)25-17-16(32-2)18(24-11-23-17)26-19(29)13-6-7-13/h10-11,13H,3-9H2,1-2H3,(H,27,30)(H2,23,24,25,26,29)	XIOWBFHAIMPXNT-UHFFFAOYSA-N	168374	US9669031, 231 6&#8242;-((6-amino-5-methoxypyrimidin-4-yl)amino)-8&#8242;-methyl-2&#8242;H-spiro[cyclohexane-1,3&#8242;-imidazo[1,5-a]pyridine]-1&#8242;,5&#8242;-dione (Cpd. No. 231)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168374	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168374&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118604474	373987109							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476337	Cc1cc(Nc2cc(NC(=O)C3CC3)ncn2)c(=O)n2c1C(=O)NC21CCN(CC(F)(F)F)CC1	InChI=1S/C22H24F3N7O3/c1-12-8-14(28-15-9-16(27-11-26-15)29-18(33)13-2-3-13)20(35)32-17(12)19(34)30-21(32)4-6-31(7-5-21)10-22(23,24)25/h8-9,11,13H,2-7,10H2,1H3,(H,30,34)(H2,26,27,28,29,33)	CFFSDCXVOIUZKT-UHFFFAOYSA-N	168375	US9669031, 232 6-((6-aminopyrimidin-4-yl)amino)-8-methyl-1&#8242;-(2,2,2-trifluoroethyl)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 232)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168375	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168375&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599111	373987110							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476338	Cc1cc(Nc2ncnc(NC(=O)C3CC3)c2C)c(=O)n2c1C(=O)NC21CCN(CC(F)F)CC1	InChI=1S/C23H27F2N7O3/c1-12-9-15(28-18-13(2)19(27-11-26-18)29-20(33)14-3-4-14)22(35)32-17(12)21(34)30-23(32)5-7-31(8-6-23)10-16(24)25/h9,11,14,16H,3-8,10H2,1-2H3,(H,30,34)(H2,26,27,28,29,33)	CDHRCFRDWKGXEQ-UHFFFAOYSA-N	168376	US9669031, 233 6-((6-amino-5-methylpyrimidin-4-yl)amino)-1&#8242;-(2,2-difluoroethyl)-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 233)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168376	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168376&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598643	373987111							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476339	COc1c(NC(=O)C2CC2)ncnc1Nc1cc(C)c2C(=O)NC3(CCN(CC(F)(F)F)CC3)n2c1=O	InChI=1S/C23H26F3N7O4/c1-12-9-14(29-17-16(37-2)18(28-11-27-17)30-19(34)13-3-4-13)21(36)33-15(12)20(35)31-22(33)5-7-32(8-6-22)10-23(24,25)26/h9,11,13H,3-8,10H2,1-2H3,(H,31,35)(H2,27,28,29,30,34)	SPKPCNAIFPZGHP-UHFFFAOYSA-N	168379	US9669031, 234 6-((6-amino-5-methoxypyrimidin-4-yl)amino)-8-methyl-1&#8242;-(2,2,2-trifluoroethyl)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 234)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168379&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118599146	373987112							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476340	COc1cncnc1Nc1cc(C)c2C(=O)NC3(CCN(CC(F)(F)F)CC3)n2c1=O	InChI=1S/C19H21F3N6O3/c1-11-7-12(25-15-13(31-2)8-23-10-24-15)17(30)28-14(11)16(29)26-18(28)3-5-27(6-4-18)9-19(20,21)22/h7-8,10H,3-6,9H2,1-2H3,(H,26,29)(H,23,24,25)	HZSXKMQIYPBWDE-UHFFFAOYSA-N	168380	US9669031, 235 6-((5-methoxypyrimidin-4-yl)amino)-8-methyl-1&#8242;-(2,2,2-trifluoroethyl)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 235)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168380	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168380&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598645	373987113							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
476341	Cc1cc(Nc2ncnc(NC(=O)C3CC3)c2C)c(=O)n2c1C(=O)NC21CCN(CC(F)(F)F)CC1	InChI=1S/C23H26F3N7O3/c1-12-9-15(29-17-13(2)18(28-11-27-17)30-19(34)14-3-4-14)21(36)33-16(12)20(35)31-22(33)5-7-32(8-6-22)10-23(24,25)26/h9,11,14H,3-8,10H2,1-2H3,(H,31,35)(H2,27,28,29,30,34)	PTSMKHQISMDSQH-UHFFFAOYSA-N	168381	US9669031, 236 6-((6-amino-5-methylpyrimidin-4-yl)amino)-8-methyl-1&#8242;-(2,2,2-trifluoroethyl)-2H-spiro[imidazo[1,5-a]pyridine-3,4&#8242;-piperidine]-1,5-dione (Cpd. No. 236)	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10.00						25.00 C	US Patent		10.7270/Q26Q1VDT		aid1795017	US9669031	Reich, SH; Sprengeler, PA; Webber, SE; Xiang, AX; Ernst, JT	6/6/2017	5/19/2018	eFFECTOR Therapeutics Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=168381	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=168381&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			118598998	373987114							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6